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CHAPTER I 
 
INTRODUCTION 
 
Overview 
It has long been known that spinal cord injury (SCI) results in paralysis.  The Edwin 
Smith Surgical Papyrus dating to 1550 BC and one of the oldest surviving surgical 
texts, describes spinal cord damage in Egyptian hieroglyphics as “One having a 
dislocation in a vertebra of his neck, while he is unconscious of his two legs and his 
two arms, and his urine dribbles.  An ailment not to be treated.”  (National Library of 
Medicine Archives).  Although our understanding of the mechanisms preventing 
functional recovery following spinal cord injury has grown significantly since this 
early observation, spinal cord injury continues to be a devastating condition for which 
we have no cure.  
In the central nervous system, axons fail to regenerate following injury due in part to 
the presence of growth inhibitory signals at the injury site.  The focus of the research 
described here was to elucidate the mechanisms of axon outgrowth inhibition by 
Myelin-associated glycoprotein (MAG), an inhibitory protein expressed on myelin 
that contributes to lack of axonal regrowth.  Chapter 1 will describe the clinical 
features and pathophysiology of spinal cord injury to underscore the importance of 
conducting studies such as those described here and to aid in the understanding of 
the disease process.  It will summarize why regeneration is limited in the CNS with a 
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particular focus on the inhibitory nature of myelin.  Chapter 1 will then move on to 
describe what is known about the biochemistry and function of MAG with regards to 
its normal functions as well as its role as an inhibitor of axon outgrowth.  Chapter 2 
will present studies carried out to identify mechanisms of cortical neuron outgrowth 
inhibition by MAG.  Although these particular neurons are often damaged in spinal 
cord injuries, very little is known about how they are inhibited.  Chapter 3 will 
describe the identification of a novel pathway involved in neurite outgrowth inhibition 
by MAG.  Chapter 4 will present work done to elucidate how one particular form of 
MAG, soluble MAG, signals to inhibit axonal growth.  Lastly, in Chapter 5 I will 
conclude by discussing important implications of this work for the regeneration field 
as well as other MAG functions and outline future experiments to identify novel 
axonal MAG receptors and enhance our understanding of how MAG signals.     
 
Anatomy of the spinal cord 
The spinal cord is encased along its length by the vertebral column and functions to 
connect the brain to the rest of the body.  A very simplified view of the spinal cord 
encompasses axons carrying information from the cortex to the spinal column to 
regulate motor function and axons carrying information from the skin to the cortex for 
processing of sensory cues.  The gray matter of the spinal cord is a butterfly shaped 
region containing neuronal cell bodies and the surrounding white matter contains 
axon tracts projecting to and from the brain.  Cortical neurons of the motor cortex 
(upper motor neurons) project via the corticospinal tract (CST) to motor neurons in 
the ventral horns of the spinal column (lower motor neurons).  Lower motor neurons 
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then project outside of the spinal cord to synapse on muscle tissue to initiate 
movement.  Peripheral sensory nerves of dorsal root ganglion neurons carry sensory 
input from sensory receptors on skin to the spinal cord.  Sensory neurons then 
transmit information to the somatosensory cortex via the dorsal column-medial 
lemniscus and anterolateral axon tracts (Figure 1.1) (Purves et al., 2002; Lin 2003).   
In addition to neurons, the central nervous system (CNS) also contains glial cells, 
which include astrocytes, oligodendrocytes, and microglia.  The main functions of 
glial cells are to provide an appropriate environment for neuronal function.  Briefly, 
astrocytes play an important role in maintaining ion homeostasis and are an 
important component, along with endothelial cells, of the blood brain barrier.  
Oligodendrocytes are the myelin forming cells of the CNS.  Oligodendrocytes extend 
a specialized, lipid-rich membrane called myelin that ensheaths axon fibers.  Myelin 
will be discussed in more detail in later sections, but its main function is to insulate 
axons and allow for rapid and more efficient nerve conduction.  Schwann cells play 
an equivalent role to oligodendrocytes in the peripheral nervous system (PNS).  
Microglia are similar to phagocytic macrophages and are important in protecting 
neurons as well as clearing debris during injury (Purves et al., 2001). 
 
Spinal Cord injury 
Epidemiology 
It is estimated that 2.5 million people live with a SCI worldwide and according to the 
International Campaign for Cures of Spinal Cord Injury Paralysis (ICCP), a 
conservative estimate of the incidence of SCI is 22 people per million with
  4 
  
Figure 1.1 Illustration of spinal cord anatomy.  A, A transverse section of the 
spinal cord showing gray and white matter as well as the corticospinal tract.  B, 
Cortical neurons project from the cortex via the corticospinal tract to motor neurons in 
the gray matter of the spinal cord.  Motor neurons then signal to muscle to regulate 
movement.  Sensory input from the skin and muscle projects through the PNS to the 
CNS where it ascends to the somatosensory cortex.  Modified from Thuret et al. 
2006. 
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approximately 130,000 people surviving a SCI annually (Thuret et al., 2006).  In the 
United States, approximately 12,000 people survive a SCI per year, with an 
estimated 262,000 people living with spinal cord injury in 2009 (National Spinal Cord 
Injury Statistical Center, NSCISC, 2010).  The average age of individuals afflicted 
with spinal cord injury is 40.2 years, with 80.8% of the cases occurring among 
males.  
The major causes of traumatic spinal cord injury as of 2005 are motor vehicle 
crashes (41.3%), falls (27.3%), violence (mostly gun shot wounds, 15%), sports 
related activities (7.9%), and other/unknown causes (8.5%). There are also many 
non-traumatic causes of spinal cord injuries, including congenital, degenerative, 
metabolic, infectious, inflammatory, ischemic, and tumorigenic (Table 1.1) 
(McDonald and Sadowsky, 2002).  The prevalence of non-traumatic SCIs is not 
known due to the heterogeneity of causes.  However, it is thought that the overall 
prevalence of SCIs would be quadrupled if non-traumatic injuries were accounted for 
(McDonald and Sadowsky, 2002).  My discussion of spinal cord injury will focus on 
traumatic injury for simplicity, but it is important to keep in mind that our 
understanding of the molecular mechanisms involved in preventing regeneration will 
aide in addressing lack of regeneration observed in traumatic and non-traumatic 
injury.    
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Clinical Features                                  
The clinical manifestations of SCI depend on the location as well as extent of the 
injury. Severity of injury is classified according to the American Spinal Injury 
Association (ASIA) Scale (Table 1.2) (McDonald and Sadowsky, 2002).  In most 
SCIs, both upper and lower motor neuron injuries are observed, due to damage to 
axon tracts (white matter) and spinal motor neurons (gray matter) respectively at the 
level of injury.  Complete injury involves most of the spinal cord at a given level in the 
spinal column and results in paralysis and loss of sensation below that level. 
Approximately 56% of traumatic SCIs impact the cervical cord, the most flexible 
region of the spinal cord, and can result in quadriparesis or quadriplegia (Rowland et 
al., 2008).  Various levels of incomplete injuries can occur depending on the neurons 
and axon tracts damaged.  Injury to specific axon tracts results in different clinical 
signs (Figure 1.2) (Dietz and Curt, 2006).  Sensation is usually retained to a greater 
extent than motor function due to the location of sensory tracts in a less susceptible, 
peripheral location in the cord.   
The prognosis of an individual suffering from spinal cord injury depends on the 
person’s age, level of injury, and severity of injury with overall life expectancy of 
individuals surviving a SCI being lower than the general population (NSCISC 2010). 
Compared to patients suffering a thoracic injury or lower, patients with a cervical 
cord injury have a significantly higher risk of death (6.6 fold for C1-C3 injury, 2.5 fold 
for C4-C5 injury, and 1.5 fold for C6-C8 injury) (Hansebout et al., 2009).  The extent 
of improvement in motor function depends on the severity of injury.  Only 10 to 15% 
of individuals with a complete injury improve, with only 3% improving to a Grade D  
  7 
 
 
  
           
Table 1.1 Non-traumatic causes of spinal cord damage 
Modified from McDonald et al. 2002 
Table 1.2 ASIA scale: Severity of injury 
Modified from Hansebout et al. 2009 
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Figure 1.2 Clinical features of spinal cord injury.  Spinal cord injury can damage a 
number of pathways in the spinal cord.  The extent of injury and the axonal tracts 
impacted by damage result in a variety of clinical manifestations.  Shown here is a 
transverse section of the spinal cord highlighting key tracts impacted by spinal cord 
injury and the clinical correlations associated with those specific tracts.  Damage to 
the corticospinal tract for example leads to paralysis. Modified from Dietz et al. 2006. 
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injury on the ASIA scale.  54% of Grade B injuries recover to Grade C or D and 86% 
of initial Grade C or D injuries will recover some walking ability.  The major causes 
odeath in individuals with spinal cord injury are pneumonia, septicemia, and 
pulmonary emboli due to immobility (NSCISC 2010).   
 
Pathophysiology 
The pathophysiology of SCI is biphasic, consisting of an initial primary injury that is 
followed by a secondary injury (McDonald and Sadowsky, 2002; Rowland et al., 
2008).  The primary injury, which is often associated with damage to the vertebral 
column, results from the trauma itself. The mechanical insult can result in 
compression, contusion, laceration, or shearing of the spinal cord.  Mechanical injury 
can directly damage axons, blood vessels, and cell membranes.  Key features of 
primary injury are hemorrhaging, swelling, and ischemia.  
The secondary damage begins approximately two hours after the primary event and 
consists of ischemia, hypoxia, inflammation, edema, excitotoxicity, loss of ion 
homeostasis, free radical production, and cell death (neurons, oligodendrocytes, and 
astrocytes) at the injury site (Thuret et al., 2006; Rowland et al., 2008).   This second 
injury phase leads to a prolonged period of tissue damage that accounts for most of 
the pathology observed in SCI and consists of various stages: early acute, 
secondary subacute, intermediate, and chronic (Figure 1.3) (McDonald and 
Sadowsky, 2002; Norenberg et al., 2004; Rowland et al., 2008).  The early acute 
phase, which lasts 2-48 hours, is characterized by ongoing hemorrhaging, rising 
edema, and inflammation.  Furthermore, secondary injury processes that advance 
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axon damage and bring about cell death begin during this phase of SCI.  Secondary 
injury progression is often accompanied with considerable neurological deterioration 
in the patient (Hansebout et al., 2009).   Free radical production peaks at 
approximately 12 hours after injury and the resulting lipid peroxidation plays a role in 
axonal membrane damage and neuronal and glial cell death.  The lack of ion 
homeostasis, especially calcium, is a key contributor to necrotic and apoptotic cell 
death at the injury site.    Extracellular glutamate levels rise following injury due to 
cell damage and deregulation of ion and glutamate transporters, resulting in 
excitotoxicity.  The high levels of glutamate receptor activation contribute to neuronal 
and glial cell death.  The early acute phase is also characterized by infiltration of 
immune cells and inflammation.  Various cell types (astrocytes, T cells, microglia, 
monocytes, and neutrophils) and inflammatory signals (TNFa, interleukins, and 
interferons) contribute to inflammation at the site of injury.  Inflammation following 
injury is a very complex process as it is thought to contribute to secondary injury 
processes as well as aid in recovery by clearing debris and providing a 
neuroprotective function.  Blood brain barrier (BBB) permeability is compromised 
during this phase of SCI due to the physical disruption of endothelial cells and 
astrocytes making up the barrier and to the effects of inflammation on vascular 
permeability.  Death of oligodendrocytes results in demyelination of axons following 
injury, a process that in rodents peaks at 24 hours after injury.     
The subacute phase of SCI lasts from 2 days to 2 weeks.  During this phase, 
phagocytes actively clear debris at the injury site.  Differences in the degree of 
clearance between the PNS and CNS may account for differences in capacity for 
  11 
  
Figure 1.3  Pathophysiology of spinal cord injury. Pathophysiology of spinal cord 
injury consists of two phases, an immediate primary phase followed by a secondary 
phase that lasts throughout the lifetime of the individual.  Shown here is a timeline of 
spinal cord injury highlighting key aspects of pathophysiology for each phase.  
Adapted from Rowland et al. 2008. 
Secondary Phase 
Primary Phase 
Wallerian degeneration 
Persistence of spared  
   demyelinated axons 
Glial scar continues to 
form 
Cyst formation 
Lesion stabilizes 
Edema 
ROS production 
Excitotoxicity 
Hemorrhage 
Necrosis 
Neutrophil Invasion 
Start of demyelination 
Oligodendrocyte, 
neuron, astrocyte death  
Axonal swelling 
Blood brain barrier 
permeability 
! 2 hours 
Early Acute Subacute Intermediate Late 
Macrophages infiltrate 
Astroglial scar begins 
 to form 
Mechanical injury 
Traumatic axon severing 
Grey matter hemorrhaging 
Necrosis 
Microglial activation 
! 48 hours ! 14 days ! 6 months " 6 months 
Time following injury 
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regeneration between the two systems.  The glial scar also forms during the 
subacute phase.  The glial scar is formed by reactive astrocytes at the outside edge 
of the lesion.  Reactive astrocytes proliferate and become hypertrophic, extending 
many, large processes that entangle to form the glial scar, a significant physical 
barrier to regeneration in the CNS.  The intermediate phase covers the time between 
2 weeks to 6 months following injury.  During this phase the glial scar matures and 
axonal sprouting can be observed.  Although sprouting is minimal and does not 
occur over long distances, the sprouting observed during this phase indicates that 
there may be potential for regrowth in the CNS.  The chronic phase begins 
approximately 6 months after injury and lasts throughout the patient’s lifetime.  
During this phase, the injury stabilizes and the scar continues to form.  The 
development of cavities or cysts that impede with ascending and descending axonal 
tracts occurs during the chronic phase and represent the final stages of injury.  Dying 
back of axons and eventual neuronal death occurs over a period of years.  Although 
CNS neurons can survive years following injury, one of the major barriers to 
regeneration and functional recovery in the CNS is the failure of axons to regrow 
past the injury site.  
Understanding the pathophysiology of spinal cord injury and the mechanisms 
underlying the various processes involved is critical to developing effective 
therapies.  Although numerous therapeutic interventions have been attempted for 
the various stages of spinal cord injury, they have had very limited success (Dietz 
and Curt, 2006; Thuret et al., 2006).  Due to the complexity of the nervous system 
and SCI pathophysiology it is likely that effective therapy will encompass multiple 
approaches and targets.  Enhancing regeneration of surviving neurons to reestablish 
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neuronal connectivity and function is an area of great interest and has thus far 
proven extremely challenging. 
 
Regeneration in the CNS 
Regeneration in the CNS and PNS 
The lack of regeneration in the adult CNS of higher vertebrates was described in 
1928 by Ramon y Cajal as “Once development was ended, the founts of growth and 
regeneration of the axons and dendrites dried up irrevocably.  In adult centers, the 
nerve paths are something fixed, ended, immutable.  Everything may die.  Nothing 
may be regenerated.” (Cajal 1928)  While axons of peripheral nerves are capable of 
regeneration following injury, central nervous system axons are not.  Ramon y Cajal 
went on to hypothesize that the capacity for regeneration of damaged axons in the 
CNS and PNS differs due to the environment in which the axons are located and not 
on the intrinsic ability of the neurons to regrow.  Several studies have supported 
Cajal’s hypothesis by showing that CNS axons are capable of regrowth if presented 
with a favorable cellular environment. 
When allowed to grow into transplanted peripheral nerves, injured CNS axons are 
able to elongate, demonstrating that these neurons have the intrinsic ability to 
regenerate.   One study transected and removed a portion of the mid-thoracic spinal 
cord in rats and replaced it with a sciatic nerve graft (Richardson et al., 1980).  
Transected CNS axons were able to grow into and cross the graft (Figure 1.4).  
Similarly, CNS axons were able to regenerate over long distances across a sciatic 
nerve bridge connecting flanking ends of a spinal cord injury (David and Aguayo, 
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1981).  Importantly, axons stopped growing when they encountered CNS tissue 
again, underscoring the inhibitory nature of the CNS milieu.  Such studies provide 
evidence that the lack of regeneration observed in the CNS is not due to intrinsic 
properties of the CNS neurons, but to the environment their axons encounter.  In 
reverse experiments, PNS neurons failed to extend processes into the CNS when 
optic nerves were implanted into sciatic nerves, further emphasizing that differences 
exist between the CNS and PNS tissues (Aguayo et al., 1978; Weinberg and 
Spencer, 1979).  In vitro, when superior cervical ganglion (SCG) or dorsal root 
ganglion (DRG) neurons were plated in a chamber slide and allowed to grow into 
optic nerve explants or sciatic nerve explants, axons grew in the sciatic nerve 
explant but were completely excluded from the optic nerve explant (Schwab and 
Thoenen, 1985), suggesting a preference for sciatic nerve tissue.  It was postulated 
that the CNS environment is not conducive to axon outgrowth, either due to the 
presence of negative regulators of outgrowth or the absence of growth promoting 
factors.  To date, most evidence points to the presence of growth inhibitory 
molecules in the CNS as the primary restraint on regeneration.  
 
Inhibitors of regeneration in the CNS 
The glial environment in the CNS, which differs considerably from that in the PNS, is 
the main inhibitor of regeneration.  Inhibitors of axon outgrowth in the CNS are 
present in the glial scar and on myelin at the injury site (Figure 1.5) (Yiu and He, 
2006).  The glial scar is a very important contributor to inhibition of regeneration in 
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Figure 1.4  CNS axons can regenerate when presented with a favorable 
environment.  A segment of rat spinal cord was removed and replaced with a sciatic 
nerve graft.  3-4 months post-injury, horseradish peroxidase (HRP) was injected 
rostral to the graft.  2 days later, spinal cords sections distal to the graft were 
analyzed for incorporation of HRP.  The image on the right represents data from four 
animals (indicated by different symbols) showing labeled axons that were able to 
cross the injury site.   Modified from Richardson et al. 1980. 
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Figure 1.5  Inhibition of axon outgrowth following injury.  A, Schematic of 
the injured spinal cord showing damaged axons with dystrophic growth cones 
as well as damaged surrounding tissue.  Axon outgrowth past the lesion is 
restricted primarily by myelin debris, which expresses several inhibitory proteins, 
as well as by astrocytes that release inhibitors of outgrowth in addition to 
contributing to the formation of the glial scar.  B,  Longitudinal section of injured 
rat spinal cords 1 month after injury containing very few neurites as shown by 
immunostaining for neurofilament (arrow, upper panel).  Myelin remnants at the 
injury site are shown by staining for MAG (arrows, bottom panel).  Adapted from 
Yiu and He 2006 and Franzen et al. 1998. 
!" #"
  17 
 
the CNS by providing a physical barrier to growth.  Furthermore, reactive astrocytes 
in and around the scar express and secrete inhibitory molecules that contribute to 
further to outgrowth inhibition (Rudge and Silver, 1990; Silver and Miller, 2004).  One 
of the biggest contributors to restricting axon growth in the glial scar is the 
expression of chondroitin sulfate proteoglycans (CSPGs) by astrocytes (McKeon et 
al., 1991; Wang et al., 1997).  CSPGs (family members include brevican, aggrecan, 
neurocan, NG2, and phosphacan) are proteins with attached sulphated 
glycosaminoglycans, moieties that are thought to be required for the inhibitory 
effects of CSPGs (Sandvig et al., 2004).  A lot remains unknown regarding CSPG 
mechanisms of axon outgrowth inhibition with possible mechanisms including a 
masking of growth promoting signals in the extracellular matrix.  However, there is 
evidence for activation of Rho GTPase by CSPG, a known negative regulator of 
regeneration, and for axonal receptors for NG2 that may mediate inhibitory signaling 
(Yiu and He, 2006).  Interestingly, although the extent of glial scarring is 
considerable in rodents, it does not appear to be as prominent a feature in humans 
(Hagg and Oudega, 2006), raising a question as to the benefit of targeting glial scar 
components therapeutically in humans.  The relative contributions of the glial scar 
and myelin, discussed in detail in the next section, to inhibition of regeneration 
remain controversial, but it is likely that both play some role in preventing regrowth of 
axons.  
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Figure 1.6 Schematic and ultrastructure of myelin in the CNS.  Oligodendrocytes 
in the CNS extend processes that ensheath axons with a specialized phospholipid 
bilayer known as myelin.  The main function of myelin is to facilitate saltatory 
conduction of action potentials from one Node of Ranvier to another and thus 
produce fast nerve conduction over long distances.  Modified from Schnaar 2010.           
!"#"$%&"'(
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Figure 1.7  Neurite outgrowth is inhibited by myelin in culture.  Myelin is a major 
contributor to neurite outgrowth inhibition in the CNS.  In vitro, neurons grown on 
myelin substrate show reduced process outgrowth.  DRGs were grown in a well 
containing control substrate on the left and myelin on the right.  While neurite 
outgrowth was observed on control substrate, it was substantially reduced on myelin.  
(Red = neuronal specific marker, TuJ1; Green = myelin) (Lee et al 2004)     
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Inhibitory nature of myelin 
The failure of axons to grow in the CNS is due to a significant extent to the inhibitory 
properties of myelin (Figure 1.6 and 1.7).  Ramon y Cajal first postulated that white 
matter opposes CNS regeneration in 1928 (Cajal 1928).  It wasn’t until 60 years later 
that Caroni and Schwab (Schwab and Caroni, 1988) provided evidence that CNS 
myelin is not permissive to neurite outgrowth while PNS myelin is.  Characterization 
of the effect of various CNS glial cells on neuronal process outgrowth revealed that 
astrocytes and immature oligodendrocytes are favorable substrates for neurite 
outgrowth.  Superior cervical ganglion (SCG), dorsal root ganglion (DRG), or retinal 
ganglion neurons plated on astrocytes or immature oligodendrocytes in culture grew 
extensive neurites that formed dense neurite networks.  However, neuronal 
adhesion and neurite outgrowth was dramatically reduced on mature 
oligodendrocytes.  Similar results are observed with neurite outgrowth of 
neuroblastoma cells and with cell spreading of fibroblasts, showing that these 
inhibitory effects are not specific to primary neurons (Schwab and Caroni, 1988). 
Because mature oligodendrocytes are the myelin producing cells in the CNS, 
experiments were carried out to test the effect of plating neurons on myelin.  Neurite 
outgrowth of SCG or DRG neurons was examined in vitro on myelin substrate.  Both 
neuron types readily extended processes on PNS myelin but not CNS myelin, where 
neurons extended short processes that made minimal contact with myelin (Caroni 
and Schwab, 1988a).  
The inhibitory nature of myelin has also been demonstrated in vivo.  Mice immunized 
with myelin generate antibodies to myelin-associated inhibitors.  Following a dorsal 
hemisection of the spinal cord of such mice, corticospinal tract fibers demonstrated 
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significant regeneration and the mice recovered significant hind limb motor function.  
Antisera from these mice also reversed the inhibitory effects of myelin on cerebellar 
neurons in culture (Huang et al., 1999).  Interestingly, there is a correlation between 
the start of myelination and the loss of axon regeneration in the CNS.  During 
development, myelination does not occur until axon outgrowth is for the most part 
complete (Lin 2003).  The capacity for chick spinal cord regeneration following injury 
disappears at a developmental stage that correlates with the start of myelination 
(Keirstead et al., 1992).  Furthermore, if the onset of myelination is delayed, the 
period of regrowth can be extended in the developing spinal cord, supporting the 
growth limiting nature of myelin (Savio and Schwab, 1990; Keirstead et al., 1992; 
Keirstead et al., 1995).  When rats are x-irradiated over the spinal cord at birth, 
oligodendrocyte differentiation and myelin formation are prevented, while other cells 
in the spinal cord, such as astrocytes are not affected.  In vitro, extracts from these 
myelin-free spinal cords were not inhibitory.  Corticospinal tract lesions were 
performed on these myelin free rats and 2-3 weeks after injury, corticospinal tract 
fibers could be seen growing long distances past the injury site as compared to 
controls (Savio and Schwab, 1990).   
The hypothesis that the CNS environment is nonpermissive for neurite outgrowth 
due to the lack of neurotrophic support is challenged by the demonstration that as in 
the PNS, neurotrophins are present in the developing and adult CNS and that 
increased neurotrophic activity is present at sites of injury (Needels et al., 1986; 
Whittemore et al., 1987).  The differences in neurite outgrowth on CNS tissue (optic 
nerve explants) and PNS tissue (sciatic nerve explants) occurred in the presence of 
high concentrations of nerve growth factor (NGF) (Schwab and Thoenen 1985).  
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Furthermore, they observed similar results with previously frozen optic or sciatic 
nerves, which did not contain living cells capable of expressing and releasing 
neurotrophins. 
In order to identify the myelin component(s) responsible for the inhibitory nature of 
CNS myelin, various fractions of myelin were tested for their ability to reduce neurite 
outgrowth.  These studies led to the identification of 35kd (NI-35) and 250kd (NI-250) 
membrane proteins on CNS myelin with strong inhibitory properties and provided the 
first evidence for the existence of molecules on myelin capable of inhibiting neurite 
outgrowth (Caroni and Schwab, 1988a).  Antibodies generated against NI-250 
neutralized the inhibitory effects of myelin, oligodendrocytes, and optic nerve 
explants on SCG neurons in vitro, supporting that the inhibitory nature of myelin is 
due to particular inhibitory proteins (Caroni and Schwab, 1988b).  NI-250 antibodies 
were also able to promote regeneration in vivo.  Rats undergoing a complete 
transection of the corticospinal tract exposed to these antibodies showed axon 
elongation up to 7-11 mm distal to the lesion site as compared to control antibody 
treated rats that experienced elongation barely exceeding 1 mm (Schnell and 
Schwab, 1990).  Importantly, only a small number of axons regenerated most likely 
due to the presence of other inhibitors.   
 
Myelin-Associated Inhibitors 
In the early 1990s several groups embarked on the search for myelin associated 
inhibitors (MAIs).  In 1994, Myelin-associated glycoprotein (MAG) was the first MAI 
to be characterized.  MAG is the focus of this thesis and will be discussed in detail in
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Figure 1.8  Function and structure of the major myelin-associated inhibitors.  A, 
The classic MAIs expressed on myelin that interact with the axon to inhibit outgrowth 
are MAG, Nogo, and OMgp. B, Cerebellar granule neuron outgrowth on MAG, Nogo 
or OMgp substrate is substantially inhibited compared to control substrate.  C,  
Schematic of MAG, Nogo-A and OMgp structures.  MAG exists as two isoforms, 
small MAG (S-MAG) and large MAG (L-MAG).  The extracellular domain consists of 5 
Ig-like domains.  The sialic acid binding site (*) is present in the first Ig domain.  The 
Nogo-A structure highlights its inhibitory 66 amino acid extracellular loop (Nogo-66).  
OMgp is a GPI-linked protein consisting of a leucine-rich repeat and a 
serine/threonine rich domain.  Modified from Mi et al., 2004 and Filbin 2003.  
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the subsequent sections.  The identity of NI-250 (see above) was established as 
Nogo-A (Nogo or RTN4) by three studies more than a decade after its 
characterization as a molecule capable of inhibiting axon outgrowth (Chen et al., 
2000; GrandPre et al., 2000; Prinjha et al., 2000).  Nogo is part of the Reticulun 
(RTN) family, which consists of three other members, RTN1, RTN2 and RTN3.  
Three Nogo protein isoforms, Nogo-A, Nogo-B and Nogo-C, are produced from the 
same gene by alternative splicing and differential promoter utilization.  Nogo-A is 
enriched in oligodendrocytes and myelin and is the best characterized as an inhibitor 
of neurite outgrowth.  Nogo-66 is a 66-amino acid extracellular loop of Nogo that 
potently inhibits neurite outgrowth and induces growth cone collapse (GrandPre et 
al., 2000).  The third key MAI to be discovered was Oligodendrocyte myelin 
glycoprotein (OMgp), a protein that is expressed on myelin and neurons in the CNS.  
OMgp is a glycosyl phosphatidylinositol (GPI) linked protein consisting of a leucine-
rich repeat (LRR) and serine/threonine rich region in its extracellular domain.  Like 
Nogo and MAG, OMgp inhibits neurite outgrowth and induces growth cone collapse 
(Wang et al., 2002b).  MAG, Nogo, and OMgp, although vastly different structurally, 
share receptors on the axon surface and are often referred to as the classic MAIs 
(Figure 1.8).  Sema4D (Moreau-Fauvarque et al., 2003) and Ephrin-B3 (Benson et 
al., 2005) are also proteins expressed on myelin capable of inhibiting axon 
outgrowth.  
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Myelin-associated glycoprotein 
Structure 
MAG is a 100-kDa type I transmembrane glycoprotein belonging to the 
immunoglobulin-like (Ig) superfamily.  MAG consists of five extracellular Ig-like 
domains, a transmembrane domain, and one of two alternatively spliced intracellular 
domains (Figure 1.8c).  The two isoforms of MAG are large MAG (L-MAG) and small 
MAG (S-MAG), which are 626 residues (72kD) and 582 residues (67kD) respectively 
and differ only in their cytoplasmic tails (Salzer et al., 1987).  
The extracellular domain of MAG contains eight N-linked glycosylation sites and is 
approximately 30% by weight carbohydrate.  Within the ectodomain is an HNK-1 
carbohydrate epitope, which is shared by many proteins involved in mediating cell-
cell interactions, such as L1 and neural cell adhesion molecule (N-CAM) (McGarry et 
al., 1983; Kruse et al., 1984).  MAG also contains an RGD sequence (Arg-Gly-Asp), 
a tripeptide sequence involved in interaction of various receptors with extracellular 
proteins (Arquint et al., 1987; Salzer et al., 1987).  MAG is a member of a subgroup 
of the Ig superfamily known as the siglec proteins (Varki and Angata, 2006; Quarles, 
2007).  Siglec group members exhibit high homology in their two amino terminal Ig 
domains and bind to sialic acid moieties on oligosaccharides.  MAG prefers α2,3-
linked sialic acid containing glycoproteins and gangliosides.  MAG is one of few 
known siglecs expressed outside of the immune system (Quarles, 2007).        
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Expression  
The expression of MAG is restricted to Schwann cells and oligodendrocytes, the 
myelin forming cells of the PNS and CNS respectively.  MAG was appropriately 
named for its localization in “myelin-associated” glial membranes as opposed to 
compact myelin.  MAG is expressed on the cell body and processes of 
oligodendrocytes prior to and during the initial stages of axonal ensheathment 
(Figure 1.9a) (Bartsch et al., 1989; Trapp et al., 1989).  After compact myelin is 
formed in the CNS, MAG is localized to the innermost periaxonal membrane, the 
myelin membrane adjacent to the axon surface, as visualized by electron 
microscopic immunocytochemistry (Figure 1.9b) (Sternberger et al., 1979; Bartsch et 
al., 1989).  MAG is quantitatively a minor myelin protein, comprising 1% of CNS and 
0.1% of PNS total myelin protein.  Although MAG expression is higher in the CNS 
than the PNS, MAG appears to be more widely distributed in the PNS than the CNS, 
with expression occurring in paranodes, Schmitt-Lanterman incisures, lateral loops, 
and mesaxons of PNS myelin (Trapp et al., 1989).  The presence of MAG at these 
locations in the CNS remains somewhat controversial.  Although early studies did 
not detect MAG at locations other than periaxonal myelin sheaths in the CNS, MAG 
was detected in paranodal regions of the optic nerve (Bartsch et al., 1989).  More 
recently, expression of a GFP tagged MAG showed localization of MAG in CNS 
paranodes, although to a lesser extent than PNS paranodes (Erb et al., 2006).   
MAG expression begins with the onset of myelination and continues throughout 
adulthood, suggesting a role for MAG in the initial process of myelin formation as 
well as the maintenance of myelin.  L-MAG and S-MAG expression is regulated 
developmentally and differs between the CNS and PNS.  In rodents, L-MAG  
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Figure 1.9  MAG is expressed on oligodendrocytes and myelin membranes.  A, 
Immunostaining for MAG in rat brain sections showing expression of MAG in the 
cytoplasm and processes (arrows) of oligodendrocytes (OL) in the newborn (top 
panel) and also along myelin sheaths (arrow) at postnatal day 5 (bottom panel). B, 
Immunoelectron microscopy of the mouse optic nerve shows compact myelin (M) 
surrounding an axon fiber (Ax).  MAG immunoreactivity can be seen at the interface 
between the inner myelin sheath and the axon. From Sternberger et al. 1979 and 
Bartsch et al. 1989.  
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expression is predominant in the CNS during development and decreases in 
adulthood.  Equal amounts of S-MAG and L-MAG were detected in the adult rodent 
CNS (Salzer et al., 1987).  However, S-MAG is the prevalent form of MAG in the 
PNS during development and in the adult.  In humans, L-MAG is the major form 
found in the adult brain and S-MAG is the predominant form in the PNS (Miescher et 
al., 1997).  Interestingly, the two isoforms of MAG are also differentially expressed 
by various subtypes of oligodendrocytes (Butt et al., 1998).  The relevance of 
developmental changes in MAG isoform expression as well as cell-type specific 
expression is not understood. 
 
Function 
Although this thesis will focus on the negative role of MAG in axonal regeneration in 
the CNS, MAG also has positive functions in the developing and mature nervous 
system in maintaining axon-myelin stability, structuring Nodes of Ranvier, and 
regulating the axonal cytoskeleton. 
The localization of MAG at periaxonal glial membranes and its extracellular features 
(Ig domains, RGD sequence, and HNK-1 epitope) suggested a role for MAG in axon-
glial interactions.  One of the first studies pointing to a role for MAG in maintaining 
the axon-glial interface arose from studies of the Quaking mouse mutant.  The 
Quaking mouse exhibits a demyelinating phenotype and expresses only 15% of the 
normal levels of MAG.  Interestingly, these mice have an abnormally wide space 
between the axon and the innermost myelin membrane in regions that do not show 
positive MAG staining by immunohistochemistry (Trapp et al., 1984).  Cell culture 
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studies were critical in ascertaining a role for MAG in regulation of axonal-glial 
interactions.  MAG antibodies blocked neuron-oligodendrocyte contact while having 
no impact on astrocyte-oligodendrocyte interactions (Poltorak et al., 1987).  
Moreover, MAG is a binding ligand in neuronal-oligodendrocyte interactions, as 
recombinant L-MAG or S-MAG, incorporated into fluorescent liposomes, bound to 
neurons when applied to cultures of spinal cord or DRG neurons (Poltorak et al., 
1987; Johnson et al., 1989).  The binding was specific, as liposomes without MAG or 
with a control protein did not bind (Johnson et al., 1989).  Furthermore, MAG 
containing liposomes did not bind to other nervous system cells including astrocytes, 
fibroblasts, or macrophages (Poltorak et al., 1987).  MAG containing liposomes 
bound preferentially to neurites of larger neurons (larger axons are preferentially 
myelinated) and binding to unmyelinated neurons, in particular cerebellar neurons, 
was either not observed or occurred to a lesser extent than neurons that are 
myelinated in vivo (Poltorak et al., 1987; Johnson et al., 1989; Sadoul et al., 1990).  
Binding of MAG incorporated liposomes to neurites in culture was not affected by 
antibodies to the HNK1 epitope or RGD containing peptides (Sadoul et al., 1990), 
suggesting that these extracellular features did not play an essential role in MAG 
binding to axons.  MAG binding also did not depend on the presence of Ca2+, 
indicating that it is a Ca2+ independent adhesion molecule (Sadoul et al., 1990).     
The role of MAG in myelin-axon stability was further supported by studies of MAG 
knockout mice.  The effect of MAG knockout on myelination is subtle and is more 
extensive in the CNS than the PNS.  However, studies of MAG knockout mice 
revealed a role for MAG in the initiation of myelination, formation of structurally intact 
myelin, and the ongoing maintenance of myelin (Li et al., 1994; Montag et al., 1994; 
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Schachner and Bartsch, 2000; Chen et al., 2006; Quarles, 2007).  As mentioned 
previously, MAG expression commences as the glial cell begins to wrap the axon.  If 
MAG were important in this initial contact we would expect that knockdown of MAG 
expression would impact the initiation of myelin formation.  Although compact myelin 
formation is normal, there is a delay in the formation of myelin during development in 
the CNS, but not the PNS in Mag-/- mice.  The optic nerves of 10-day-old Mag-/- 
mice demonstrated a 50% decrease in the density of retinal ganglion axons 
encircled by compact myelin compared to control animals (Montag et al., 1994).  
Adult Mag-/- mice also showed hypomyelination of the optic nerve, with 34.7% of 
axons remaining hypomyelinated at 2 months in the knockout mice compared to 
11.7% of axons in age-matched wild-type controls (Bartsch et al., 1997).   This 
difference decreased with age with 9-month-old Mag-/- mice having 18.2% 
unmyelinated retinal ganglion axons compared to 8.5% of control mice.       
Overall, myelin tracts formed normally in Mag-/- mice as observed by 
immunocytochemistry for MBP and compact myelin lamellar organization was 
normal as demonstrated by X-ray diffraction (Li et al., 1994). Furthermore, myelin 
thickness and caliber of myelinated fibers were similar between Mag+/+ and Mag-/- 
mice (Li et al., 1994).  However, more subtle defects in myelination were detected by 
electron microscopy.  While one report observed a normal periaxonal space in mag-
/- mice (Montag et al., 1994), a different study found that the periaxonal space of 
mag-/- mice was dilated in the CNS and PNS compared to wild-type mice, indicating 
axonal separation from their myelin sheaths (Li et al., 1994).  A consistent defect 
observed in the CNS of Mag-/- mice was missing or disorganized periaxonal 
cytoplasmic collars (Li et al., 1994; Montag et al., 1994).  Only 5% of Mag-/- mice 
  31 
contained a fully developed periaxonal cytoplasmic collar, compared to 75% in wild-
type mice (Montag et al., 1994).  The absence of MAG resulted in other 
abnormalities, including redundant compact myelin, the presence of oligodendrocyte 
cytoplasm within compact myelin, and the occurrence of supernumerary myelin 
sheaths (Li et al., 1994; Montag et al., 1994).  Not unexpectedly, the nerve and 
motor function defects of Mag-/- mice were also subtle.  Electrophysiological 
evaluation of Mag-/- sciatic nerves revealed a slight, but significant reduction in 
conduction velocity compared to wild-type sciatic nerves (Fruttiger et al., 1995; 
Weiss et al., 2000).  Overall motor function and posture appeared normal in open 
field experiments.  However under conditions that require fine motor coordination or 
balance, such as crossing a bar-cross apparatus, exploratory sniffing, or grooming, 
decreased motor activity was observed (Li et al., 1994).  
Mag-/- mouse pathology became more prominent with maturity and effects on PNS 
myelination became more evident.  Studies of aging Mag-/- mice revealed findings 
similar to those found in demyelinating conditions that are consistent with a 
breakdown of the myelin-axon interaction, resulting in glial and axonal pathology. 
Biochemical analysis of myelin and myelinated axons demonstrated that several 
molecular changes occur in CNS myelin that are consistent with 
oligodendrogliopathy (Weiss et al., 2000).  Comparison of 14-month-old Mag-/- and 
Mag+/+ mice revealed decreases in 2’,3’-cyclic nucleotide 3’-phosphodiesterase 
(CNPase), neural cell adhesion molecule (N-CAM), tubulin, Na+K+ATPase, and Fyn 
tyrosine kinase in Mag-/- mice, all indicative of changes in oligodendrocyte health.  
These findings are supported by the morphological finding of degenerating 
periaxonal oligodendroglial processes in 8-month-old Mag-/- mice (Lassmann et al., 
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1997).  Degenerative changes observed in oligodendrocyte processes of Mag-/- 
mice include the presence of multivesicular bodies, an abundance of mitochondria, 
lipofuscin granules and a variety of inclusions.  Further support for the role of MAG in 
maintaining properly myelinated axons is the presence of degenerating axons in 
older Mag-/- mice.  Axonal pathology occurred in the PNS and CNS of older Mag-/-  
mice and was characterized by axonal swelling, myelin figures, ovoids, decreased 
axonal diameter, decreased expression and phosphorylation of neurofilaments, and 
ultimately axonal degeneration (Fruttiger et al., 1995; Yin et al., 1998; Weiss et al., 
2000; Loers et al., 2004; Pan et al., 2005).  Older mice also exhibited abnormal 
motor behavior. Mag-/- mice performed worse than wild-type mice on rotarod tests, 
which gauge balance and motor control (Pan et al., 2005). 
MAG also contributes to the timely structuring and maturation of the Nodes of 
Ranvier (Figure 1.6).  Formation of intact Nodes of Ranvier involves the 
development of three discrete regions within the node: the node itself, where sodium 
channels are highly expressed, the contiguous paranodes, which are characterized 
by Caspr expression, and the juxtaparanodes which are rich in potassium channels 
(Susuki and Rasband, 2008).  In Mag-/- spinal cords, immunostaining for these 
various components of the node revealed a more diffuse distribution of expression, 
with overlap occurring amongst the various regions (Marcus et al., 2002).  Nodal 
structural abnormalities in Mag-/- mice include a reduction in reversed lateral glial 
loops and transverse bands, which are likely due to defects in axonal-glial 
interactions.  Importantly, these defects were not detected in mature mice, 
suggesting that the proper organization of the nodes is delayed but not prevented. 
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As mentioned above, lack of MAG expression in aging mice resulted in axonal 
degeneration.  One of the changes observed in aged Mag-/- axons was modification 
of neurofilament expression and phosphorylation. Myelination influences 
neurofilament organization in normal axons (Hsieh et al., 1994).  Myelinated 
segments of DRG axons have a larger caliber, increased neurofilament expression, 
and increased space between neurofilaments compared to unmyelinated regions 
(Hsieh et al., 1994).  There is evidence that MAG is a component of myelin that 
contributes to the regulation of the axonal cytoskeleton.  Decreased axonal caliber, 
diminished neurofilament spacing, and lower neurofilament phosphorylation were 
detected in the sciatic nerves of Mag-/- mice compared to wild-type mice (Yin et al., 
1998).  To verify that the effects of MAG knockout on the axonal cytoskeleton were 
directly due to MAG signaling and not a secondary effect of changes in the axonal-
glial interaction, studies were conducted in vitro.  Embryonic DRG neurons were 
plated on MAG expressing CHO cells and subsequently stained for various neuronal 
components (neurofilament, microtubule-associated protein B1, MAP2, and tau) all 
of which were upregulated on MAG.  Neurons on MAG expressing cells also had 
increased expression of phosphorylated neurofilament.  These results were 
confirmed by the detection of increased phosphorylated neurofilaments in PC12 cells 
treated with soluble MAG (Dashiell et al., 2002).      
             
MAG reverse signaling 
When glial cells and neurons interact, MAG is capable of both reverse and forward 
signaling, influencing glial and axonal biology respectively. Reverse signaling, which 
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for the most part remains obscure, will be briefly discussed here. Forward signaling 
by MAG, which has received considerably more attention, will be discussed in detail 
later with regards to the effect of MAG on neurite outgrowth. 
The intracellular domains of L-MAG and S-MAG contain several putative 
phosphorylation sites (Arquint et al., 1987; Salzer et al., 1987), the phosphorylation 
of which impacts their ability to interact with glial cytoplasmic components.  Both S-
MAG and L-MAG can be phosphorylated on various serine and threonine residues 
on their cytoplasmic domains (Edwards et al., 1988; Kirchhoff et al., 1993).  Protein 
kinase A (PKA) and protein kinase C (PKC) have both been identified as candidate 
kinases for MAG (Kirchhoff et al., 1993; Kursula et al., 2000).  L-MAG is tyrosine 
phosphorylated, whereas S-MAG is not.  Tryptic digest analysis of 32P-labeled MAG 
revealed that one of the major tyrosine phosphorylation sites on MAG in 
oligodendrocytes is Tyr-620 (Jaramillo et al., 1994).  Phosphorylated MAG interacts 
with phospholipase C gamma (PLCγ) in vitro and in vivo and phosphorylation at Tyr-
620 is required for this interaction.  
MAG also interacts with Fyn, a tyrosine kinase.  Fyn can be co-immunoprecipitated 
with L-MAG and S-MAG from total brain lysates (Jaramillo et al., 1994; Umemori et 
al., 1994), an interaction that is mediated by the SH2 and SH3 domains of Fyn.  
Crosslinking the extracellular domain of MAG with a MAG antibody resulted in 
increased Fyn phosphorylation and activity in COS cells expressing MAG, but not 
other tyrosine kinases such as Src (Umemori et al., 1994).  Fyn and MAG also 
colocalized by immunostaining in mouse axon tracts and oligodendrocytes during 
myelination (Umemori et al., 1994).  The interaction between Fyn and MAG is 
thought to contribute to axonal-glial interactions during myelination.  Additional 
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intracellular binding partners such as S100β (Kursula et al., 1999) and tubulin 
(Kursula et al., 2001) have been identified for L-MAG and S-MAG respectively.  To 
date, very little is known regarding the functional significance of the aforementioned 
interactions and the biological relevance of MAG phosphorylation.  
 
Inhibition of neurite outgrowth by MAG 
Regulation of neurite outgrowth by MAG   
The search for myelin-associated inhibitors occurred at a time when very few 
proteins with neurite outgrowth inhibitory properties had been characterized.  MAG 
was the first myelin-associated inhibitor to be identified (McKerracher et al., 1994; 
Mukhopadhyay et al., 1994).  MAIs were purified by subjecting myelin extracts to 
diethylaminoethyl anion exchange column chromatography followed by salt gradient 
elution (McKerracher et al., 1994).  Eluted fractions were utilized as a substrate for 
NG108-15 cells (neuroblastoma cell line) and tested for their ability to inhibit neurite 
outgrowth of these cells.  One inhibitory fraction that dramatically reduced the 
percent of cells with neurites was enriched with a 100kDa protein.   The 100kDa 
protein was confirmed by Western blot analysis to be MAG.  Furthermore, 
immunodepletion of MAG from the column eliminated the inhibitory activity of this 
particular inhibitory fraction.  The inhibitory effect of MAG on neurite outgrowth was 
confirmed more directly by experiments showing that the extracellular domain of 
MAG also inhibited neurite outgrowth of NG108-15 cells when used as a substrate.  
Interestingly, poorly glycosylated MAG, lacking the L2/HNK-1 epitope, still 
dramatically inhibited neurite outgrowth, suggesting that carbohydrates on MAG are 
  36 
likely not essential for outgrowth inhibition.  To investigate the contribution of MAG to 
the inhibitory effect of myelin, MAG was immunodepleted from myelin extracts.  
Neurite outgrowth on MAG depleted myelin was recovered to 63% of control levels, 
suggesting that MAG contributes significantly to the inhibitory activity of myelin.  
These findings also revealed that additional inhibitors exist on myelin to inhibit 
neurite outgrowth.  This is supported by the presence of other inhibitory fractions in 
column chromatography experiments of myelin extracts (McKerracher et al., 1994). 
CHO cells expressing MAG on the cell surface were used to test the effect of MAG 
on neurite outgrowth of primary neurons (Mukhopadhyay et al., 1994).  Postnatal 
cerebellar granule neuron (CGNs) and adult dorsal root ganglion (DRG) neuron 
outgrowth was inhibited (decreased average neurite length) on MAG expressing 
CHO cells when compared to control CHO cells or CHO cells expressing a control 
myelin protein.  MAG antibodies reversed the inhibitory effect of MAG on neurite 
outgrowth, confirming that inhibition by MAG expressing CHO cells was due to MAG.  
MAG also inhibited neurite outgrowth of a variety of other primary neuron 
populations, including retinal ganglion, superior cervical ganglion, hippocampal, and 
spinal neurons (Figure 1.10a and 1.10b) (DeBellard et al., 1996). 
Interestingly, MAG is a bifunctional molecule in regards to axon outgrowth, acting to 
both promote and inhibit it (Figure 1.10c).  These contrasting effects depend on the 
type of neuron as well as its maturity.  The outgrowth promoting effects of MAG were 
first reported on perinatal DRG neurons (Johnson et al., 1989).  Postnatal day 1 
DRG neurons were plated on MAG expressing fibroblasts and found to have longer 
processes than neurons plated on control fibroblasts (Johnson et al., 1989).  While 
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Figure 1.10  MAG is a bifunctional regulator of neurite outgrowth.  A, B, MAG 
inhibits neurite outgrowth of various postnatal neuronal populations.  Neurons were 
grown on MAG expressing (black bars) or control CHO (hatched bars) cells and 
immunostained for GAP-43, a neuronal marker. A, Images of cerebellar neurons on 
control CHO or MAG-CHO cells. B, Neurite outgrowth was assessed by measuring 
neurite length.  CN = cerebellar RN = retinal ganglion HN = hippocampal SN = spinal 
SCG = superior cervical ganglion neurons  C, MAG has been shown to positively 
regulate neurite outgrowth of young neurons and negatively regulate neurite 
outgrowth of more mature neurons.  While postnatal day 1 DRG neurite outgrowth 
was increased on MAG-CHO cells compared to control CHO cells, adult DRG neurite 
outgrowth was reduced.  Modified from DeBellard et al., 1996 and Mukhopadhyay et 
al., 1994. 
A 
B C 
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newborn DRG neurite outgrowth is promoted by MAG, adult DRG neuron outgrowth 
is inhibited (Mukhopadhyay et al., 1994; Cai et al., 2001).  DRGs demonstrate a 
switch from outgrowth promoting to outgrowth inhibiting effects by MAG at postnatal 
day 3 (DeBellard et al., 1996).  MAG also promotes the outgrowth of several types of 
embryonic neurons, including retinal ganglion cells (RGCs) (Cai et al., 2001), spinal 
neurons (Turnley and Bartlett, 1998), and raphe nuclei neurons (Cai et al., 2001), 
while inhibiting these same neurons postnatally.   The mechanisms of enhancement 
of neurite outgrowth by MAG are not known and require future investigation.  
However, due to the relevance of MAG inhibition of neurite outgrowth to CNS injury, 
much effort has gone into understanding how MAG inhibits neurite outgrowth in the 
CNS.  
 
MAG Receptors 
Several neuronal receptors have been identified for MAG (Figure 1.11) (Xie and 
Zheng, 2008; Schnaar and Lopez, 2009; Cao et al., 2010).  I will introduce these 
various receptors and their signaling partners and also discuss the controversies 
surrounding the role of individual receptors in neurite outgrowth inhibition by MAG. 
The best characterized receptor on the axon surface that binds Nogo, MAG, and 
OMgp is Nogo receptor 1 (NgR1 or NgR), an 85kDa GPI anchored protein that 
participates in a tripartite-signaling complex to transduce growth inhibitory signals 
intracellularly (Figure 1.12).  NgR is a brain-specific member of the leucine-rich 
repeat (LRR) superfamily made up of 8 LRRs and a cysteine-rich LRR flanking 
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Figure 1.11 Schematic of axonal receptors involved in neurite outgrowth 
inhibition by MAG.  Several receptors have been implicated in MAG signaling.  
NgR1, NgR2, PirB and gangliosides have been characterized as binding partners for 
MAG on the axon surface.  p75 and TROY are co-receptors for NgR1 involved in 
transducing MAG’s inhibitory signal intracellularly.  Adapted from Cao et al 2010. 
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Figure 1.12  A tripartite signaling complex mediates Rho activation and neurite 
outgrowth inhibition by MAG.  MAG binds to NgR1 on the axon surface, which 
forms a complex with p75 and LINGO1 to signal intracellularly.  The binding of Rho-
GDI to p75 and proteolysis of p75 have both been implicated in Rho activation and 
subsequent ROCK activation by MAG.  Modified from Xie and Zheng 2008.   
p75 cleavage 
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region in its extracellular domain and a GPI link (Fournier et al., 2001; McGee and 
Strittmatter, 2003).  NgR is most highly expressed in neurons and axons of the CNS 
but is also expressed in the PNS (Josephson et al., 2002; Wang et al., 2002c).  NgR 
was first identified as an axonal receptor for Nogo-66 (Fournier et al., 2001) and 
subsequently established as a receptor for MAG  (Domeniconi et al., 2002; Liu et al., 
2002).  Application of phosphatidylinositol-specific phospholipase C (PI-PLC) to 
CGNs or DRG neurons rendered them less resistant to inhibition by MAG, 
supporting a role for a GPI linked receptor in inhibition by MAG (Domeniconi et al., 
2002; Liu et al., 2002).  MAG binds to NgR1 and interfering with NgR1 function by 
way of a function blocking antibody or a soluble ectodomain of NgR reversed 
inhibition of DRG or CGN neurite outgrowth inhibition by soluble MAG (MAG-Fc) or 
MAG expressing CHO cells (Domeniconi et al., 2002).  Interestingly, expression of 
NgR in embryonic neurons that are not normally inhibited by MAG, rendered them 
responsive to MAG inhibition (Liu et al., 2002).  Two mammalian homologs have 
been described for NgR1, NgR2 and NgR3 (Lauren et al., 2003).  All three NgRs are 
highly expressed in the CNS and PNS and exhibit both unique and overlapping 
patterns of expression.  NgR2, but not NgR3, can also function as a receptor for 
MAG (Venkatesh et al., 2005).  MAG interacts with NgR2 with high affinity and 
exogenous application of recombinant NgR2 reversed neurite outgrowth of DRG 
neurons and CGNs on detergent extracts from MAG-CHO cells.  Unlike NgR1 and 
others, NgR2 appears to serve as a receptor selectively for MAG, as it does not bind 
Nogo or OMgp.  Of note, cleavage of GPI linked proteins by PI-PLC did not 
completely eliminate the susceptibility of many neurons to inhibition by MAG, 
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suggesting the presence of other, non-GPI-linked, receptors on the axon surface for 
MAG (Niederost et al., 2002). 
Since NgR is GPI anchored it requires a co-receptor to signal intracellularly. Two 
such co-receptors have been identified for NgR, p75 neurotrophin receptor (p75) and 
TROY (also known as Taj), both members of the tumor necrosis factor receptor 
(TNFR) superfamily. P75 is a type I transmembrane receptor with the characteristic 
four cysteine-rich extracellular repeats of TNFR family members, a highly conserved 
transmembrane domain, and an intracellular “death domain”.  Best known as a 
neurotrophin receptor, p75 also binds additional ligands including pro-neurotrophins, 
prion protein fragment (PrP), and Aβ-peptide of the amyloid precursor protein (APP) 
(Hasegawa et al., 2004a).  P75 is a multifunctional receptor, interacting with 
numerous transmembrane and cytoplasmic proteins and playing a role in a range of 
biological functions (Dechant and Barde, 2002; Hasegawa et al., 2004a). The 
foremost function of p75 is in developmental and disease related neuronal cell 
death, however other functions for p75 are emerging in processes such as 
promotion of axonal elongation, myelin formation, synaptic transmission, and neurite 
outgrowth inhibition.   
Several lines of evidence support a role for p75 in transducing the growth inhibitory 
signals initiated by several MAIs.  Crossing a p75 knockout mouse with an NGF 
overexpressing transgenic mouse demonstrated robust outgrowth of p75 null 
sympathetic neurons into myelinated portions of the cerebellum in comparison to 
wild-type neurons, suggesting that in the presence of p75, an inhibitory cue exists to 
prevent neurite outgrowth in response to myelin proteins (Walsh et al., 1999).  There 
is evidence that p75 is up-regulated following axotomy or lesions (Ernfors et al., 
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1989; Roux et al., 1999), indicating that although not normally expressed in high 
levels in many adult neurons, p75 expression can be regulated following injury to 
mediate inhibition of outgrowth.  Furthermore, a role for p75 was shown in neurite 
outgrowth stimulation in response to NGF.  Expression of the receptor activated Rho 
GTPase in the absence of ligand, but neurotrophin binding to p75 stimulated axon 
outgrowth and inactivated Rho (Yamashita et al., 1999).  The first evidence backing 
a role for p75 in MAI signaling was that p75 knockout DRG or CGN neurite 
outgrowth was not inhibited by MAG-Fc whereas p75 wild-type neurons were 
significantly inhibited (Yamashita et al., 2002).  Subsequent work demonstrated that 
cultured neurons from p75 knockout mice were less responsive to growth inhibitory 
signals induced by all known NgR ligands (Wang et al., 2002a; Yamashita et al., 
2002).  Interfering with p75 function also abolished Xenopus neuronal growth cone 
turning by MAG (Wong et al., 2002).  p75 participated in a physical complex with 
NgR, forming an interaction that is strengthened by the presence of MAG (Wang et 
al., 2002a; Wong et al., 2002; Yamashita et al., 2002).  Furthermore, disrupting the 
interaction between p75 and NgR via application of p75-Fc (the extracellular domain 
of p75 fused to Fc) to cultures or neuronal overexpression of NgR that is incapable 
of binding p75, blocked neurite outgrowth inhibition and Rho activation by MAG-Fc 
(Wang et al., 2002a).  p75 is also necessary for regulation of Rho GTPase signaling 
downstream of several MAIs.  CGNs treated with MAG showed increased activation 
of Rho, whereas p75 mutant CGNs did not exhibit increased Rho activity in response 
to MAG (Yamashita et al., 2002). The lack of Rho activation in p75 null neurons was 
also shown with Nogo, OMgp, and myelin extracts (Wang et al., 2002a).  
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We have since gained significant insights into the mechanism by which p75 activates 
Rho.  Overexpression of a p75 mutant lacking the receptor’s cytoplasmic tail in 
CGNs desensitized the neurons to inhibition by MAG-Fc, suggesting that the 
intracellular domain of p75 is required for inhibitory signaling by MAG (Wang et al., 
2002a).  P75 interacted with Rho GDP dissociation inhibitor (Rho-GDI), an 
interaction that was strengthened by MAG-Fc (Yamashita and Tohyama, 2003).  The 
binding of Rho-GDI by p75 releases Rho from this inhibitor, thereby facilitating GTP 
binding and activation.  Overexpression of Rho-GDI or Pep5, a peptide that disrupts 
the Rho-GDI / p75 interaction abolished the effect of MAG-Fc on neurite outgrowth 
of DRG neurons and CGNs as well as preventing activation of Rho by MAG-Fc 
(Yamashita and Tohyama, 2003).   
MAG-Fc can induce regulated intramembrane proteolysis of p75 by the γ-secretase 
complex in CGNs and, inhibitors of the protease reversed neurite outgrowth 
inhibition by MAG-CHO cells as well as MAG-Fc (Domeniconi et al., 2005).  
Secretase inhibitors also blocked activation of Rho by MAG-Fc in CGNs and 
expression of a noncleavable mutant of p75 in DRGs prevented the inhibitory effects 
of MAG-CHO cells.  These results led the authors to suggest that cleavage of p75 is 
an important step in neurite outgrowth inhibition. The mechanisms by which p75 
proteolysis regulates Rho have yet to be determined. 
The third member of the NgR/p75 complex is LRR and Ig domain containing, Nogo 
receptor interacting protein (LINGO1).  Like NgR, LINGO1 is a member of the LRR 
superfamily with an extracellular domain consisting of 12 LRRs and an Ig domain, 
but unlike NgR, LINGO1 also has a transmembrane domain and an intracellular 
domain.  It is postulated, (but unknown) that the intracellular domain of LINGO may 
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play a role in signaling events downstream of MAIs.  Not much is understood 
regarding the function of LINGO1, except that its presence in the NgR-p75-LINGO1 
complex is required for inhibition of neurite outgrowth and the regulation of Rho 
GTPases by several MAIs (Mi et al., 2004). 
p75 can function as a signaling partner for NgR in the inhibition of neurite outgrowth, 
but many populations of mature neurons do not express p75 (Park et al., 2005).  
Furthermore, although p75 knockout neurons are less responsive to MAIs, there is 
still some inhibition of neurite outgrowth (Wang et al., 2002a) suggesting the 
presence of another receptor capable of transducing MAI signaling.  A search for 
TNFR family members, other than p75, that are expressed in the CNS and could 
interact with NgR lead to the identification of TROY as a member of the NgR 
complex (Mandemakers and Barres, 2005; Park et al., 2005; Shao et al., 2005).    
TROY was identified as a co-receptor for NgR that can functionally substitute for p75 
in neurite outgrowth inhibition signaling (Park et al., 2005; Shao et al., 2005).  Co-
immunoprecipitation experiments show that TROY forms a complex with NgR and 
LINGO1.  When expressed in CHO or COS-7 cells, with NgR and LINGO1, TROY 
mediates activation of Rho by MAIs.  Neuronal over expression of a mutant TROY 
lacking its intracellular domain or application of soluble TROY in neurite outgrowth 
assays reversed outgrowth inhibition by Nogo-66, OMgp, or myelin (Park et al., 
2005; Shao et al., 2005).  TROY is more widely expressed in mature neurons than 
p75 (Park et al., 2005) and may be important for mediating MAI signaling in neurons 
lacking p75.  Notably, even when p75 and TROY function is abolished, there is still 
some residual neurite outgrowth inhibition, hinting at additional receptors involved in 
this process.   It is important to note that a role for TROY in MAG signaling has not 
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been shown, as the experiments mentioned above were conducted with MAIs other 
than MAG.  
Gangliosides have also been proposed as receptors for MAG, although the exact 
contribution and role of gangliosides in MAG function remain largely controversial 
(McKerracher, 2002; Schnaar and Lopez, 2009; Cao et al., 2010).  Gangliosides are 
sialic acid containing glycosphingolipids that are highly and broadly expressed in the 
brain (Schnaar, 2010).  MAG contains a sialic acid binding site in its extracellular 
domain and binds various gangliosides (Schnaar et al., 1998).  A mutant soluble 
MAG lacking its sialic acid binding capacity inhibited hippocampal neuron outgrowth 
to a lesser extent than wild-type MAG (Vinson et al., 2001).  Two groups identified 
gangliosides GD1a and GT1b as receptors for MAG in the inhibition of neurite 
outgrowth of CGNs and hippocampal neurons (Vinson et al., 2001; Vyas et al., 
2002).  Treatment of neurons with neurominidase, inhibitors of ganglioside 
biosynthesis, or class specific ganglioside antibodies to GD1a or GT1b significantly 
reversed neurite outgrowth inhibition by MAG-CHO membranes or MAG-Fc.  
Additionally CGNs obtained from mice lacking complex gangliosides were less 
susceptible to inhibition by MAG (Vyas et al., 2002).   
It has been postulated that MAG inhibits neurite outgrowth by clustering gangliosides 
on the cell surface, as antibody provoked clustering of GD1a or GT1b recapitulated 
neurite outgrowth inhibition by MAG (Vinson et al., 2001; Vyas et al., 2002).  The 
mechanism by which gangliosides mediate neurite outgrowth inhibition is unknown. 
A role for the Rho GTPAse effector Rho kinase (ROCK) was suggested by 
demonstrating that the inhibition obtained by antibody induced ganglioside clustering 
can be reversed by Y27632 (a ROCK inhibitor) (Vinson et al., 2001).  Conversely, 
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several studies have questioned the importance of gangliosides in MAG signaling 
(Tang et al., 1997a; Cao et al., 2007) and future studies will be needed to shed light 
on these differences.  
The most recently identified receptor for MAG is Paired-immunoglobulin-like receptor 
B (PirB).  PirB is a major histocompatibility complex class I (MHCI) receptor that 
along with MHCI functions in the remodeling or stabilization of neural circuits (Syken 
et al., 2006).  Specifically, mice lacking PirB show increased cortical ocular-
dominance plasticity, indicating that PirB normally functions to restrict plasticity in the 
CNS.  PirB is expressed in various subsets of neurons including cortical, 
hippocampal, and cerebellar neurons.  PirB was identified as a receptor for Nogo-66, 
MAG, and OMgp following an expression cloning screen for Nogo-66 binding 
partners (Atwal et al., 2008).  A soluble extracellular domain of PirB or a function 
blocking PirB antibody partially reversed CGN or DRG neurite outgrowth inhibition by 
soluble Nogo-66 or MAG as well as myelin.  Moreover, neurons from PirB mutant 
mice, bearing a loss-of-function PirB allele, showed decreased inhibition by MAG, 
Nogo-66, and OMgp.   
To address whether PirB and NgR jointly mediate inhibition by MAIs, a function-
blocking antibody was added to cultures of NgR-/- neurons in the presence of Nogo-
66 or myelin.  Blocking the function of both receptors fully reversed inhibition by 
myelin but not Nogo-66 (Atwal et al., 2008).  Similar studies were not conducted with 
MAG.  The mechanism by which PirB inhibits neurite outgrowth is not known.  
However, PirB complexes with src homology 2–containing protein tyrosine 
phosphatases (SHP-1 and SHP-2) in the brain (Syken et al., 2006).  SHP-2 acts as a 
“stop” signal for neurons approaching their targets (Chen et al., 2002). Recruitment 
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of SHP-1 or SHP-2 to PirB in response to myelin inhibitors may play a role in 
mediating neurite outgrowth inhibition.  
 
Recent controversies 
It was initially presumed that the classic NgR complex, NgR-p75/TROY-LINGO1, 
was responsible for mediating inhibition by Nogo, MAG, and OMgp in most neuronal 
populations.  However, over the last few years, MAG signaling in particular, has 
become increasingly complex, with many studies casting doubt on the extent to 
which these receptors function in vitro and in vivo.  With the development of NgR1 
knockout mice, the latest studies suggest that the role of NgR in MAI signaling is 
more complicated than initially anticipated.  Genetic deletion of NgR1 reduced the 
extent of growth cone collapse elicited by soluble Nogo, MAG and OMgp in culture in 
one study (Kim et al., 2004).  On the other hand, wild-type and NgR1-/- CGNs and 
DRGs were similarly susceptible to neurite outgrowth inhibition by Nogo-66 or myelin 
substrate (Zheng et al., 2005).  These discrepancies may be explained by a recent 
study investigating neurite outgrowth inhibition by MAG and OMgp in NgR-/- neurons 
and neurons where NgR was knocked down by shRNA (Chivatakarn et al., 2007).  
Growth cone collapse, an acute effect where the growth cone loses its fan shaped 
structure and the axon retracts, in response to soluble ligands and inhibition of 
outgrowth, where the axon is exposed to the ligand long term and fails to advance, in 
response to membrane bound ligands were evaluated.  While NgR was required for 
acute growth cone collapse by soluble MAG and OMgp, it was not required for the 
more chronic effect on neurite outgrowth when neurons were plated on cells 
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expressing MAG or OMgp.  Together, these studies are supportive of a role for NgR 
in the acute effects of myelin-associated inhibitors, but indicate that other receptors 
are likely contributing to the inhibition of process outgrowth. 
There is emerging evidence of neuronal type-specific mechanisms of neurite 
outgrowth inhibition by MAG.  Wild-type and p75 null RGCs and CGNs were equally 
inhibited by MAG-CHO cells, bringing into question the role of p75 in MAG mediated 
neurite outgrowth inhibition in these two neuron populations (Venkatesh et al., 2007).  
However, p75-/- DRG neurons were significantly less inhibited by MAG-CHO cells as 
compared to wild-type neurons, supporting a role for the receptor in one of the 
neuron types investigated.  The contribution of NgR, gangliosides and p75 to the 
inhibition of various neuron types by MAG substrate was analyzed using diverse 
enzymes and pharmacological inhibitors (Mehta et al., 2007).  They found that while 
NgR and p75 largely mediated inhibition of DRG neuron outgrowth, CGN inhibition 
was mostly mediated by gangliosides and did not appear to require p75.  Our current 
understanding of mechanisms of inhibition by MAG, especially with regards to its 
receptors, has become somewhat confounded.  Inhibition by MAG depends on the 
age and type of neuron and whether growth cone collapse or inhibition of outgrowth 
is assessed.  As new receptors are identified, such as PirB, our comprehension of 
MAG signaling will undoubtedly become clearer.  Importantly, these recent 
discoveries indicate that reversing inhibition of regeneration of particular axon tracts 
will require further investigation of specific neuron populations.  
The effects of MAIs on cortical neurons, one of the principal neuronal types impacted 
by SCI, remains poorly characterized.  Many efforts to regrow the corticospinal tract 
(CST) following injury have proven unsuccessful.  Regeneration of the CST was not 
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observed in NgR-/- mice following a dorsal hemisection (Zheng et al., 2005).  
Likewise CST regeneration was not observed following injury of p75-/- mice (Song et 
al., 2004).  It is likely that if neuronal-specific mechanisms of outgrowth inhibition 
occur, we have yet to identify all receptors and signaling pathways required for 
inhibition of the corticospinal tract.  The mechanisms identified thus far have been 
characterized in neurons other than cortical neurons.  The work that will be 
presented in the subsequent chapters, set out to characterize the mechanisms of 
cortical neuron outgrowth inhibition by MAG in the hope of identifying molecules and 
pathways that can be targeted to reverse injury to this specific neuron type.   
 
MAG signaling in neurite outgrowth inhibition  
Understanding axonal signaling mechanisms downstream of MAG and other 
inhibitors of axon outgrowth is an area of great interest due to implications for 
therapeutic interventions. In order to cause growth cone collapse and axon 
outgrowth inhibition, many inhibitors ultimately act on the cytoskeleton to regulate 
actin dynamics.  To date, Rho GTPase family members, which include Rho, Rac, 
and Cdc42, are the best-characterized axonal signaling intermediates involved in 
MAI regulation of the cytoskeleton (Sandvig et al., 2004; Govek et al., 2005). Rho 
GTPase is a common target of various inhibitors of axon outgrowth including those 
found on myelin or in the glial scar.  RhoA stimulates actinomycin contractility and 
stress fiber formation in neuronal cells, inducing growth cone collapse (Hall, 1998; 
da Silva and Dotti, 2002).  Rac and Cdc42 positively regulate axon growth, Rac 
contributing mostly to formation of lamellipodia and Cdc42 to the formation of 
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filopodia at the leading edge of the axon.  Rac and Cdc42 contribute to the 
polymerization of actin, formation of cell protrusions, and provide the force 
necessary for movement of the growth cone (da Silva and Dotti, 2002; Govek et al., 
2005). 
Neuronal stimulation by MAG and other MAIs results in increased Rho activity 
(Niederost et al., 2002; Yamashita et al., 2002; Borisoff et al., 2003; Dubreuil et al., 
2003; Fournier et al., 2003).  Rho GTPase pulldown assays showed that soluble 
MAG and Nogo-66 can activate Rho in PC12 cells, CGNs, and DRGs (Niederost et 
al., 2002; Fournier et al., 2003).  The balance of Rho and Rac GTPases seems to be 
important for determining whether axon outgrowth can occur, with Rho negatively 
regulating neurite outgrowth and Rac enhancing neurite outgrowth.  While MAIs 
counter neurite outgrowth by activating Rho, there is also evidence that they 
simultaneously inhibit Rac (Niederost et al., 2002).  
A critical role for Rho is supported by studies in which MAI mediated outgrowth 
inhibition is reversed with C3 exoenzyme (C3), a specific pharmacological inhibitor of 
Rho (Lehmann et al., 1999; Dergham et al., 2002).  Primary RGCs treated with C3 
extended more and longer neurites on MAG substrate (Lehmann et al., 1999).  
Complete reversal of CGN neurite outgrowth inhibition by MAG-CHO cells has been 
previously demonstrated following C3 application (Niederost et al., 2002).  Rho 
signals through various effector proteins, molecules that bind to the active GTP 
bound form of Rho and regulate multiple downstream pathways (O'Donnell et al., 
2009).  Two Rho effectors that have been implicated in neurite outgrowth inhibition 
are p160ROCK (ROCK-I) and ROK-Rho-kinase (ROCK-II).  Treatment of cortical 
neurons grown on myelin with Y27632, an inhibitor of ROCK-I and ROCK-II, 
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reversed the effect of myelin on the average length of the longest neurite (Dergham 
et al., 2002).  Reversal of CGN neurite outgrowth inhibition by MAG-CHO cells and 
DRG inhibition by soluble MAG was observed in the presence of Y27632 (Niederost 
et al., 2002).  LIM kinase and its target Cofilin, an actin modifying protein, are 
downstream of ROCK in the inhibition of axon outgrowth by MAIs (Alabed et al., 
2006).  Myosin light chain (MLC) has also been implicated in ROCK mediated 
inhibition of neurite outgrowth by MAIs (Alabed et al., 2006).  
In addition to a clear role in inhibition by MAIs in vitro, Rho plays a role in vivo.  Rho 
is activated following spinal cord injury (Dubreuil et al., 2003; Madura et al., 2004).  
GTP-Rho pull-down assays of spinal cord homogenates from rats with various 
injuries (contusions, hemisections and transections) revealed increased Rho activity 
in injured spinal cords when compared to control spinal cords (Dubreuil et al., 2003).  
Activation of Rho in spinal cord injuries was also confirmed by in situ visualization of 
increased GTP bound Rho in injured spinal cords compared to sham-operated cords 
(Dubreuil et al., 2003; Madura et al., 2004).  Inhibition of Rho or ROCK in vivo has 
established these signals as negative regulators of axon regeneration.  C3 treatment 
of crushed optic nerves resulted in significant axon growth past the lesion site into 
white matter (Lehmann et al., 1999).  Enhanced sprouting of CST fibers and 
significant locomotor recovery were observed with Y27632 treatment (Fournier et al., 
2003). However, in this study axonal outgrowth of corticospinal tracts following injury 
was not observed with C3 treatment, possibly due to ineffective delivery of the 
inhibitor.   Application of C3 or Y27632 at the site of a spinal cord dorsal hemisection 
resulted in significant regeneration of CST fibers as well as functional recovery in 
locomotion and coordination (Dergham et al., 2002).  More recently, genetic 
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manipulation of ROCKII revealed that this kinase plays a role in the restriction of 
axon outgrowth following spinal cord injury (Duffy et al., 2009).  While many axons 
were found to cross the lesion site with inhibition of Rho or ROCK, it remains 
unknown what other mechanisms of inhibition exist and whether pursuing additional 
targets could improve the regeneration thus far observed with C3 or Y27632 
treatment. 
Although considerably less well understood, additional neuronal intracellular signals 
have been implicated downstream of MAG.  MAG induced an increase in 
intracellular Ca2+ when applied to HEK 293 cells expressing NgR and p75 (Wong et 
al., 2002).  When applied to Xenopus spinal neurons or CGNs, MAG produced an 
increase in intracellular calcium levels, which was required for growth cone repulsion 
in spinal neurons (Song et al., 1998; Wong et al., 2002).   Conventional isoforms of 
PKC were also reported to contribute to neurite outgrowth inhibition by MAIs, 
including MAG, and CSPGs associated with the glial scar (Hasegawa et al., 2004b; 
Sivasankaran et al., 2004).  Pharmacological inhibition of PKC reversed CGN neurite 
outgrowth inhibition by soluble MAG.  Furthermore, application of soluble MAG to 
CGNs resulted in increased PKC activation, as substantiated by elevated levels of 
phosphorylated PKC (Hasegawa et al., 2004b; Sivasankaran et al., 2004).  
Interestingly, while one study found that PKC is required for Rho activation by 
soluble MAG in CGNs (Sivasankaran et al., 2004), another found that Rho activation 
by MAG is independent of PKC in the same neuronal population (Hasegawa et al., 
2004b). 
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Evidence for soluble MAG 
I have mentioned the use of soluble MAG (MAG extracellular domain) experimentally 
at several points thus far.  Although MAG is assumed to interact with the axon as a 
membrane bound protein, several studies support the occurrence of soluble MAG in 
vitro.  The release of MAG from the surface of oligodendrocytes is supported by the 
presence of a smaller molecular weight MAG in oligodendrocyte culture medium 
(Yim and Quarles, 1992).  Following mechanical disruption of rat myelin and 
incubation, the extracellular domain of MAG was detected in the supernatant, 
supporting the notion that MAG can be released from myelin (Tang et al., 1997b).  
Proteolytic cleavage and release of MAG from MAG expressing CHO cells can be 
induced by recombinant matrix metalloproteinases, specifically MMP-2, MMP-7, or 
MMP-9 (Milward et al., 2008).  Several studies have gone on to show that MAG 
released from myelin or the cell surface inhibits neurite outgrowth in neuronal 
cultures (Tang et al., 1997b; Tang et al., 2001; Milward et al., 2008).  Many of the 
early studies investigating mechanisms of MAG signaling in outgrowth inhibition 
utilized soluble MAG.  More recent observations, some of which seem contradictory 
to initial findings (see above section) may be due to differences in how MAG is 
presented to the axon, that is, as a soluble versus membrane bound form. The 
extent of MAG cleavage that occurs in vivo, under normal conditions and following 
injury, and the mechanism of cleavage remains unclear. 
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Aims of the dissertation  
I hypothesize that given the very limited success in stimulating corticospinal tract 
regeneration in vivo, cortical neurons are particularly susceptible to outgrowth 
inhibitors, such as MAG.  Given the emerging evidence for neuronal cell-type 
specific mechanisms of inhibition by MAG, I propose that cortical neurons may be 
inhibited by unique or multiple mechanisms. I set out to address this hypothesis with 
the following Specific Aims: 
Specific Aim 1:  Characterize cortical neurite outgrowth inhibition by MAG 
 a.  Investigate the response of cortical neurons to MAG inhibition     
 b. Examine the role of known MAG receptors in inhibition of cortical neurite  
               outgrowth 
c.  Explore whether the Rho / ROCK pathway mediates neurite outgrowth   
    inhibition by MAG in cortical neurons  
Specific Aim 2:  Investigate a role for PTEN in cortical neurite outgrowth inhibition by 
MAG 
 a.  Study the effect of PTEN knockdown or knockout on responsiveness of  
                cortical neurons to MAG 
 b.  Examine whether increasing phosphorylated Akt levels in cortical neurons  
                impacts inhibition by MAG    
 c. Analyze whether MAG induces changes in Akt activation in cortical  
               neurons   
Specific Aim 3:  Explore mechanisms of neurite outgrowth inhibition by soluble MAG 
 a.  Investigate whether TRAF6 plays a role in outgrowth inhibition by soluble  
                MAG     
 b. Delineate the mechanism by which TRAF6 mediates neurite outgrowth  
               inhibition by soluble MAG  
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CHAPTER II 
 
CHARACTERIZATION OF NEURITE OUTGROWTH INHIBITION BY MAG  
IN CORTICAL NEURONS 
 
Introduction 
The limited regrowth of axons following injury in the mammalian central nervous 
system (CNS) can result in debilitating and often permanent neurological deficits. 
Myelin, produced by oliogodendrocytes to facilitate saltatory conduction, expresses a 
number of proteins that inhibit axonal growth and are thought to contribute to 
preventing regeneration. These myelin-associated inhibitors include Nogo A, Myelin-
associated glycoprotein (MAG), Oligodendrocyte myelin glycoprotein (OMgp), 
Ephrin-B3, and Sema4D (Filbin, 2003; Yiu and He, 2006).  
MAG, one of the most extensively studied myelin-associated inhibitors, is a 
transmembrane glycoprotein expressed on periaxonal myelin membranes in the 
peripheral and central nervous systems.  It plays a physiological role in maintaining 
myelinated axons as well as contributing to the pathology of demyelinating diseases 
and the inhibition of CNS regeneration (Filbin, 2003; Quarles, 2007).  Several 
neuronal receptors have been identified for MAG, including the Nogo receptors 
(NgR1 and NgR2) (Domeniconi et al., 2002; Liu et al., 2002; Venkatesh et al., 2005), 
gangliosides GD1a and GT1b (Yang et al., 1996; Vinson et al., 2001; Vyas et al., 
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2002), and the more recently identified paired immunoglobulin-like receptor B (PirB) 
(Atwal et al., 2008). 
Understanding how the various receptors contribute to the inhibition of axon 
outgrowth by MAG has proven remarkably complex. NgR1 is a 
glycosylphosphatidylinositol-linked protein that binds MAG and signals through 
interaction with the p75 neurotrophin receptor (p75NTR) (Wang et al., 2002a; Wong 
et al., 2002) or a homologous protein, Taj/TROY (Park et al., 2005; Shao et al., 
2005), and the novel transmembrane protein LINGO1 (Mi et al., 2004). The NgR 
complex was recently reported to function in an additive manner with the PirB 
receptor, such that inhibiting both receptors was necessary to fully reverse the 
effects of myelin (Atwal et al., 2008).  The effects of MAG depend on an interaction 
with gangliosides, at least in some neurons (Vyas et al., 2002; Mehta et al., 2007); 
however, this remains controversial (Cao et al., 2007; Schnaar and Lopez, 2009).  It 
has been suggested that MAG’s inhibitory effects involve different receptors 
depending on the type of neuron and the nature of the inhibition, such as acute 
growth cone collapse versus more long-term axon extension (Chivatakarn et al., 
2007; Mehta et al., 2007; Venkatesh et al., 2007).  
How these various MAG receptors transduce their signals to inhibit axon growth is 
also not well understood. The NgR1 complex can activate the GTP binding protein 
RhoA, which regulates the actin-cytoskeleton, leading to growth cone collapse and 
the prevention of neurite outgrowth (Hall, 1998; Niederost et al., 2002; Wang et al., 
2002a; Yamashita et al., 2002).  However, a role for intracellular calcium (Song et 
al., 1998; Wong et al., 2002) and protein kinase C (PKC) (Hasegawa et al., 2004b; 
Sivasankaran et al., 2004) has also been suggested downstream of NgR-p75NTR-
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LINGO1. The mechanisms by which gangliosides and PirB signal have yet to be 
determined, although an association between PirB and the phosphatases Shp-1 and 
Shp-2 has been reported (Syken et al., 2006). 
We set out to investigate the receptors and intracellular signaling pathways involved 
in MAG-mediated inhibition of neurite outgrowth, specifically in cortical neurons. One 
of the pathways often damaged in spinal cord injury is the corticospinal tract, 
resulting in debilitating clinical manifestations including paralysis (Joosten, 1997; 
McDonald and Sadowsky, 2002). However, very few studies have investigated how 
cortical neurons respond to myelin-associated inhibitors and the mechanisms 
underlying their inhibition.   
Our results demonstrate that cortical neuron process growth is robustly inhibited by 
MAG, but the inhibition could not be reversed by deletion of p75NTR or by blocking 
gangliosides or PirB.   Surprisingly, inhibition of Rho signaling only partially reversed 
the effect of MAG, indicating the presence of additional intracellular signals.  
 
Experimental Procedures 
Primary neuron cultures   
Cerebellar granule neuron (CGN) cultures were prepared from postnatal day 4-7 
mice.  Cerebella were isolated, dissociated in 0.125% trypsin (Worthington) at 37oC 
for 15 min, washed in PBS, triturated and subsequently plated in Neurobasal media 
(Gibco) containing B27 supplement (Gibco), 25mM KCl, 33mM dextrose, 2mM 
glutamine, and 100U/ml penicillin / 100µg/ml streptomycin (Gibco).  Cortical neurons 
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were isolated at E15-E17 or postnatal day 1-3, dissociated in 0.06% trypsin 
(Worthington) for 30 min at room temperature, triturated and plated in Neurobasal 
media with B27 supplement on dishes coated with 2µg/ml laminin (Invitrogen) or on 
CHO cells for neurite outgrowth assays. 
 
Immunostaining 
Cells were fixed in 3.7% formalin, blocked with 10% normal goat serum in PBS 
containing 0.2% triton X-100, incubated with primary antibody overnight and 
visualized with fluorescently labeled secondary antibodies and mounted with 
medium containing DAPI (Vectashield, Vector Labs).  For MAG immunostaining, the 
permeabilization step was omitted.  Primary antibodies used: anti-TuJ1 (1:500, 
Covance), anti-MAG (10 µg/ml, Chemicon) and anti-PirB (A-20, 1:50, Santa Cruz).  
Secondary antibodies used: goat anti-mouse Alexa 488 (1:500, Invitrogen) and 
donkey anti-goat Alexa 488 (1:500, Invitrogen). 
 
Neurite outgrowth assay  
Neurite outgrowth assays on MAG transfected CHO cells have been previously 
described (Mukhopadhyay et al., 1994).  Cortical neurons or CGNs (40,000/well) 
were plated on confluent monolayers of MAG-CHO or control CHO cells in 8 well 
tissue culture slides (Lab-Tek, Nalge Nunc International).  After incubation for ~20 
hours, co-cultures were fixed and immunostained with anti-TuJ1, as described 
above.  Where indicated, compounds were added at the time of neuronal plating: cell 
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permeable C3 exoenzyme (1µg/ml, Cytoskeleton, CT04), Y27632 (100µM, Sigma), 
neurominidase (40mU/ml, MP Biomedicals), function blocking PirB antibody 
(50µg/ml, kindly provided by M. Tessier-Lavigne, Genentech, CA). The percent of 
neurons with neurites was quantified in a blinded manner using a Zeiss fluorescence 
microscope at 40x magnification.  A neurite was defined as a process at least twice 
the length of the cell body. For each experiment, 2-4 wells were used for each 
condition and at least 250 neurons were counted per condition.  Neurite lengths 
were determined using ImageJ software analysis of images taken with a Zeiss 
fluorescence microscope at 40x magnification.  The longest neurite  ≥1 cell body was 
measured for each neuron, with at least 145 neurites evaluated for each 
experimental condition. 
 
Mice 
CD1 mice (Charles River) and C57BL/6 mice with the p75 gene deleted (Lee et al., 
1992) were used, as indicated.  All experiments with animals were approved by the 
Animal Care and Use Committee at Vanderbilt University. 
 
HEK293 cell transfections   
HEK293 cells, maintained in DMEM with 10% fetal bovine serum, were transfected 
with constructs expressing p75 (in pcDNA3) or TROY (in pFLAG-CMV-1) using 
Lipofectamine (Invitrogen) according to the manufacturer’s protocol. The TROY 
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plasmid was generously provided by Zhigang He (Harvard Medical School, Boston, 
MA) (Park et al., 2005).     
 
Western blot analysis  
Cells were lysed in NP40 lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% 
NP-40, 10% glycerol) containing a protease inhibitor cocktail (Complete Mini, 
Roche).  Cell lysates were subjected to SDS-PAGE and Western blotting using anti-
p75NTR (1:1000, generated from a GST fusion protein with the p75NTR intracellular 
domain), anti-TROY (1:500, E19, Santa Cruz) or anti-α-tubulin (1:1000, 
Calbiochem).  Secondary antibodies conjugated to horseradish peroxidase included 
anti-rabbit (1:3000, Thermo Scientific) and anti-mouse (1:3000, Promega).  For CHO 
cell membrane isolation, MAG-CHO cells or control CHO cells were harvested, 
incubated on ice for 30 min in homogenization buffer (20 mM Hepes, 1.5 mM MgCl2, 
1 mM EGTA, and protease inhibitor cocktail), homogenized with a dounce 
homogenizer, and spun down at 3,000 rpm for 10 min at 4oC.  The resulting 
supernatant was then centrifuged at 16,000rpm for 1 hr at 4oC.  The pellet was 
analyzed by non-reducing Western analysis for MAG expression (10 µg/ml anti-
MAG, Covance). 
 
Apoptosis analysis   
Cortical neurons were plated on control CHO or MAG-CHO cells.  ~20 hrs following 
initial plating, neurons were fixed and stained with TuJ1 antibody and mounted with 
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DAPI containing medium.  Apoptotic cells were analyzed by counting condensed, 
pyknotic nuclei and the ratio of pyknotic nuclei to total neurons counted per field are 
represented as % apoptotic nuclei.  
 
Results 
Neurite outgrowth in cortical neurons is potently inhibited by MAG 
To evaluate the effects of MAG on neurite outgrowth from cortical neurons, 
embryonic neurons (E15-17) isolated from mouse cortex were plated on CHO cells 
stably expressing MAG on the cell surface (MAG-CHO cells) or control CHO cells 
(Figure 2.1). After approximately 20 hours, neurons were assessed for neurite 
outgrowth.  Neurites were detected on 43.0% of the neurons on the control CHO 
cells; however, only 6.7% of the neurons on MAG-CHO cells displayed neurite 
outgrowth (Figure 2.2a).  Neurite lengths were also considerably diminished on 
MAG-CHO cells, with a 53.6% reduction in neurite length compared to control CHO 
cells (Figure 2.2a).  Since the corticospinal tract does not form until after birth in 
rodents (Bastmeyer and O'Leary, 1996), we also decided to analyze the effects of 
MAG on early postnatal cortical neurons.  Using cortical neurons from P1-P3 pups, 
we found a comparable reduction in neurite outgrowth by MAG (Figure 2.2a). The 
dramatic reduction in neurite outgrowth was not due to cell death as there was no 
difference in the percent of apoptotic neurons on MAG-CHO cells (13.6%) as 
compared to control CHO cells (14.3%) (Figure 2.2b). 
We performed similar neurite outgrowth experiments with CGNs, a neuron type often 
used to study inhibition of axonal growth by myelin proteins such as MAG. As
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Figure 2.1.  Neurite outgrowth assay on MAG expressing CHO cells.  A, Non-
permeabilized CHO cells and MAG-CHO cells were immunostained with anti-MAG to 
verify cell surface expression of MAG.  CHO cell and MAG-CHO cell membranes 
were isolated and analyzed by Western blot analysis for MAG expression.  B, 
Overview of neurite outgrowth assay.  Primary neurons are plated on MAG 
expressing CHO cells or control CHO cells, grown for 20 hours, fixed and 
immunostained for Tuj1, a neuronal specific marker.  A representative image is 
shown of neurons on CHO cells (shown by Dapi).  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Figure 2.2.  Cortical neuron outgrowth is dramatically inhibited by cell surface 
expressed MAG.  A, Embryonic (E15-17) or postnatal (P1-3) cortical neurons were 
plated on control CHO or MAG-CHO cells for ~20 hrs then fixed and stained for TuJ1. 
Neurite outgrowth was measured as the percent of neurons with neurites or length of 
the longest neurite per neuron. Representative images are shown of embryonic 
cortical neuron cultures and the quantified data depicted below.  Data represents 
mean ± SEM. For % neurons with neurites, n=8 for embryonic neurons and n=2 for 
postnatal neurons with 2-3 replicates per experiment.  For length analysis, n=3 with 2 
replicates per experiment. B, The percent of apoptotic neurons on control CHO and 
MAG-CHO cells was determined for embryonic cortical neurons.  There was no 
significant difference between conditions based on a Student’s t-test. Data represent 
mean ± SEM (n=4). C, Neurite outgrowth of CGNs on control CHO and MAG-CHO 
cells was quantified. Data represents mean ± SEM (n=6 for % neurons with neurites, 
n=3 for neurite length). (*, p<0.01, **, p<0.0003 based on a Student’s t-test.)  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expected, neurite outgrowth was significantly reduced (Figure 2.2c); however, the 
response of cortical neurons to MAG was substantially greater than that of CGNs.  
We observed an 86.0% reduction in the percent of embryonic cortical neurons with 
neurites, a 71.1% reduction in outgrowth of postnatal cortical neurons, but only a 
34.1% reduction in outgrowth of CGNs.  Similarly, we detected a 34.5% reduction in 
neurite length in CGNs on MAG-CHO cells relative to control CHO cells, compared 
to 53.6% for cortical neurons.  These results suggest that cortical neurons are 
particularly sensitive to inhibition by MAG, raising the question as to the underlying 
mechanisms.  
 
The effect of MAG on cortical neuron outgrowth is independent of its known 
receptors  
MAG signals through a complex of the NgR1, p75NTR and LINGO1 in several types 
of neurons (Schnaar and Lopez 2009).  In order to characterize the receptors playing 
a role in cortical neurite outgrowth inhibition by MAG, we first analyzed the 
expression of p75NTR and TROY in embryonic mouse cortex and cortical cultures, 
since these are the signal transducers in the tripartite complex.  P75NTR was 
detected in cortical tissue as well as cortical neuron cultures, but there was no 
detectable signal for TROY (Figure 2.3a).  Therefore, we investigated whether 
p75NTR was necessary for mediating the effects of MAG in cortical neurons.  When 
plated on MAG expressing CHO cells, neurite outgrowth from both p75ntr+/+ and 
p75ntr-/- neurons was similarly inhibited (Figure 2.4a), indicating that this receptor is 
  66 
               
Figure 2.3.  Expression of MAG receptors in cortical neurons.  A, Lysates from 
E15 cortex, P6 cerebellum or cortical neuron cultures were analyzed by Western blot 
with antibodies to p75NTR or TROY. HEK 293 cells overexpressing p75NTR or 
TROY served as positive controls.  B, Embryonic cortical neuron cultures were 
immunostained with an antibody to PirB.  Staining in which primary antibody was 
omitted is included as a control.  
  67 
 
not required for the response to surface bound MAG.  As a comparison, we analyzed 
outgrowth p75ntr+/+ and p75ntr-/- CGNs on MAG-CHO cells and found a similar 
response in both genotypes (Figure 2.4a). These results suggest that membrane 
bound MAG does not signal through the p75NTR-NgR-LINGO1 complex in cortical 
neurons or CGNs. 
Gangliosides may also contribute to the inhibitory effect of MAG on neurite 
outgrowth, particularly in CGNs and hippocampal neurons (Mehta et al., 2007).  
Since GT1b and GD1a are expressed in cortical neurons (Lee et al., 2007), we 
investigated whether gangliosides mediate the MAG effect in cortical neurons. 
Neurons plated on MAG-CHO or control CHO cells, were treated with neurominidase 
to cleave off sialic acid moieties, which are required for MAG binding to GT1b and 
GD1a (Vyas et al., 2002). In agreement with previous studies (DeBellard et al., 1996; 
Venkatesh et al., 2007), we observed significant reversal of CGN neurite outgrowth 
on MAG-CHO cells in the presence of neurominidase.  However, even with 
concentrations as high as 40 mU/ml there was no significant increase in outgrowth of 
cortical neurons on MAG-CHO cells (Figure 2.4b), indicating that membrane bound 
MAG signals independent of gangliosides in these neurons. 
Recently, Atwal et al (2008) identified PirB as a functional receptor for the myelin-
associated inhibitors, including MAG.  In agreement with previous findings (Syken et 
al., 2006), we detected PirB in cortical neurons (Figure 2.3b); therefore we 
investigated its role in mediating the effects of MAG on neurite outgrowth. Cortical 
neurons were plated on control CHO or MAG-CHO cells in the presence of a PirB 
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 Figure 2.4. Inhibition of neurite outgrowth in cortical neurons by MAG is not mediated by p75NTR, gangliosides or PirB. A, p75ntr+/+ or p75ntr-/- postnatal 
cortical neurons or CGNs were plated on control CHO or MAG-CHO cells for ~20 hrs, 
at which point the cells were fixed and stained for TuJ1.  Neurite outgrowth was 
measured as the percent of neurons with neurites. Data represent mean ± SEM (n=2, 
2-4 replicates per experiment). B, Cortical neurons or CGNs were plated on control 
CHO or MAG-CHO cells in the presence of neurominidase (40 mU/ml).  Significant 
difference in the inhibition of neurite outgrowth was detected for CGNs, but not for 
cortical neurons. Data represents mean ± SEM (n=2, 2 replicate wells per 
experiment). C, Cortical neurons or CGNs were plated on control CHO or MAG-CHO 
cells in the presence of 50µg/ml of control antibody (human IgG) or PirB antibody.  In 
CGNs, anti-PirB significantly reduced the inhibitory effects of MAG (n=3). However, 
there was no significant difference in the inhibition of neurite outgrowth by MAG in 
cortical neurons treated with anti-PirB (n=4). Data represents mean ± SEM.  (*, 
p<0.05, **, p<0.01, ***, p<0.001 by two way ANOVA).  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function-blocking antibody that reversed the inhibitory effects of myelin proteins in 
dorsal root ganglia (DRG) neurons and CGNs (Atwal et al., 2008).  
However, blocking PirB did not significantly attenuate the inhibition of neurite 
outgrowth by membrane bound MAG (Figure 2.4c). Increasing the concentration of 
the antibody 4-fold did not provide any further increase in neurite growth (data not 
shown). In contrast, there was a significant, although only partial, rescue of CGN 
neurite outgrowth on MAG-CHO cells in the presence of the PirB antibody (Figure 
2.4c) in agreement with Atwal et al (2008). Taken together, these results 
demonstrate that membrane bound MAG prevents axonal growth in cortical neurons 
independent of the known receptors, suggesting there is another receptor system yet 
to be identified. 
 
Inhibiting Rho or ROCK partially rescues cortical neuron outgrowth on a MAG 
substrate 
Previous studies demonstrated that the GTPase RhoA and its effector Rho kinase 
(ROCK) are key mediators of the inhibitory effects of MAG in CGNs and DRG 
neurons (Lehmann et al., 1999; Niederost et al., 2002; Fournier et al., 2003; Alabed 
et al., 2006) and the NgR1-p75-LINGO1 complex can activate this pathway (Wang et 
al., 2002a; Yamashita et al., 2002; Yamashita and Tohyama, 2003). Therefore, to 
determine whether this cascade also contributes to the inhibition of neurite outgrowth 
by MAG in cortical neurons we treated the cells with C3 exoenzyme (C3), a Rho 
inhibitor, or Y27632, a ROCK inhibitor.  As a positive control, we confirmed that both 
compounds could fully reverse the inhibition of neurite outgrowth by MAG in CGNs
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Figure 2.5.  Inhibition of neurite outgrowth in cortical neurons by MAG is 
partially reversed by blocking Rho signaling.  A, Cortical neurons (left panel) were 
harvested and plated on control CHO or MAG-CHO cells in the presence of vehicle or 
cell permeable C3 exoenzyme (1µg/ml).  20 hrs after plating, neurons were fixed and 
immunostained for TuJ1. Neurite outgrowth was measured as the percent of neurons 
with neurites. Data represents mean ± SEM (n=4).  Similar experiments were 
conducted with CGNs (right panel) (n=2).  B, Cortical neurons (left panel) or CGNs 
(right panel) were plated on control CHO or MAG-CHO cells in the presence of 
vehicle or the ROCK inhibitor Y27632 (100µM).  20 hrs after plating the neurons were 
fixed and immunostained for TuJ1. Neurite outgrowth was measured as the percent 
of neurons with neurites. Data represent mean ± SEM (n=2). (*, p<0.05, **, p<0.01, 
***, p<0.001 by two way ANOVA).   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(Figure 2.5a and 2.5b, respectively).  Surprisingly, C3 or Y27632 only partially 
reversed the inhibition of neurite outgrowth in cortical neurons (Figure 2.5a and 
2.5b). Both compounds rescued process extension to an equivalent extent, 
consistent with Rho and ROCK acting in the same pathway. Thus, although Rho and 
ROCK play a significant role in mediating the effects of MAG in cortical neurons, 
there must be other signaling pathways involved.  
 
Discussion 
Cortical neurons are frequently damaged in spinal cord injury and fail to regenerate, 
in part, due to the presence of growth inhibitory proteins at the site of injury. 
Furthermore, recent findings suggest that inhibitors expressed by myelin may 
normally function in the refinement of cortical circuitry during development (McGee 
et al., 2005). However, very little is known about how cortical neurons respond to 
specific, endogenous inhibitors of axon growth. Here, we investigated the response 
of cortical neurons to MAG, a myelin protein known to prevent axonal outgrowth in 
other neurons. Our results indicate that both embryonic and postnatal cortical 
neurons are particularly sensitive to inhibition of neurite outgrowth by MAG. 
Interestingly, the effects of MAG were not mediated by any of its known receptors 
and inhibition of the Rho/ROCK pathway only partially reversed neurite outgrowth 
inhibition by MAG.   
MAG is a multifunctional, transmembrane protein expressed on the periaxonal 
surface of myelinating cells in both the peripheral and central nervous system. It is 
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important for long-term axon-myelin stability and for proper structuring of Nodes of 
Ranvier (Quarles, 2007; Schnaar and Lopez, 2009). In addition, MAG regulates 
axonal growth, being able to promote it or inhibit it depending on the type of neuron 
as well as the developmental stage.  MAG enhances neurite outgrowth from a 
number of embryonic neurons, including retinal ganglion cells (Cai et al., 2001), 
spinal neurons (Turnley and Bartlett, 1998; Cai et al., 2001), and dorsal root ganglia 
(DRG) neurons (Johnson et al., 1989; Mukhopadhyay et al., 1994; DeBellard et al., 
1996; Cai et al., 2001), whereas postnatal axon outgrowth of these neurons is 
inhibited. In cortical neurons, we observed dramatic inhibition of neurite outgrowth by 
MAG at both embryonic (E15 to E17) and postnatal (P1-3) ages.  
The mechanisms by which MAG mediates these various signals are poorly 
understood. Due to the relevance for spinal cord injury, much attention has focused 
on elucidating the signals responsible for inhibiting axonal growth. The best 
characterized receptor complex mediating the effects of MAG is the one formed by 
the gpi-linked Nogo receptor, p75NTR or TROY and LINGO1. However, we found 
that p75NTR was not involved in preventing neurite outgrowth in cortical neurons 
and no expression of TROY was detectable (Fig. 2). These results are in agreement 
with those of Chivatakarn et al (2007) who found that cortical neurons from mice with 
NgR1 deleted were as responsive to MAG-CHO cells as wild-type neurons. Since 
MAG can also bind NgR2 (Venkatesh et al., 2005), it is possible these results could 
be explained by NgR2 substituting for NgR1. However, taken together with our 
findings, the more likely conclusion is that the NgR-p75NTR-LINGO1 complex is not 
required for the inhibition of neurite out growth by membrane-bound MAG in cortical 
neurons.  
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The role of the NgR-p75NTR-LINGO1 complex in mediating the effects of MAG 
appears to depend on the type of neuron and the form of MAG used. For example, 
wild-type and p75ntr null retinal ganglion cells (RGCs) and CGNs were equally 
inhibited by MAG-CHO cells; however, p75ntr-/- DRG neurons were significantly less 
inhibited than wild-type neurons, suggesting that membrane-bound MAG signals 
through p75NTR in DRGs but not RGCs or CGNs (Venkatesh et al., 2007). In 
contrast, numerous reports have demonstrated a requirement for p75NTR in 
mediating the response of CGNs to a soluble fragment of MAG containing the 
extracellular domain (Wang et al., 2002a; Yamashita et al., 2002; Yamashita and 
Tohyama, 2003). A soluble form of MAG has been detected following incubation of 
spinal cord extracts in vitro (Tang et al., 2001), but whether this cleaved product of 
MAG is generated after neuronal injury is not known. Ultimately, a major objective of 
studies on MAG’s ability to inhibit neurite outgrowth is to understand how 
regeneration could be facilitated following axonal damage in vivo. However, p75ntr-/- 
mice do not exhibit any significant improvement in regeneration of the CST following 
spinal cord injury, indicating that this receptor does not have a major role in 
preventing axonal growth from cortical neurons in vivo (Song et al., 2004; Zheng et 
al., 2005). 
Two other receptors have been reported for MAG, the gangliosides GT1b and GD1a, 
and PirB, a major histocompatibility complex class 1 receptor. However, we found 
that neither of these molecules significantly contributed to the inhibitory effects of 
MAG in cortical neurons.  Of course we cannot rule out the possibility that the 
concentration of PirB antibody used was not high enough to disrupt the interaction of 
MAG with cortical neurons.  Although not statistically significant, there was a trend 
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toward a partial reversal of the inhibition by MAG with anti-PirB.  However, taken 
together, these results suggest that there exists an additional, yet to be identified 
receptor for membrane-bound MAG that transduces a signal preventing neurite 
outgrowth in cortical neurons. 
Down stream of many signals inhibiting process outgrowth and extension in cells are 
the small GTPase Rho and its effector kinase ROCK. Increased Rho activity has 
been detected in neurons following spinal cord injury (Dubreuil et al., 2003; Madura 
et al., 2004) and application of the Rho inhibitor C3 or the ROCK inhibitor Y27632 at 
the site of injury resulted in significant, although limited, regeneration of corticospinal 
tract fibers as well as functional improvement in locomotion and coordination 
(Dergham et al., 2002; Fournier et al., 2003). Similarly, genetic deletion of ROCKII 
revealed that this kinase plays a role in restricting axon outgrowth following spinal 
cord injury (Duffy et al., 2009).  MAG increased Rho activity in neurons (Lehmann et 
al., 1999; Niederost et al., 2002; Yamashita et al., 2002; Fournier et al., 2003) and, 
not unexpectedly, we found that inhibiting Rho or ROCK significantly reversed the 
effect of membrane-bound MAG on cortical neurons.  However, we were surprised 
to find that blocking Rho or ROCK was only partially effective in the cortical neurons; 
significant inhibition of neurite outgrowth remained in the neurons plated on MAG-
CHO cells when C3 or Y27632 was added. This result suggested that membrane-
bound MAG was activating additional growth inhibitory signals. 
The results shown here indicate that membrane bound MAG inhibits outgrowth of 
cortical neurons through novel mechanisms.  In particular, unidentified MAG 
receptors are present on the axonal membrane to mediate inhibition by MAG.  Also, 
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in addition to Rho, other intracellular signals exist to mediate cortical neurite 
outgrowth inhibition by MAG. 
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CHAPTER III 
 
MAG INHIBITS NEURITE OUTGROWTH IN CORTICAL NEURONS THROUGH A 
PTEN DEPENDENT MECHANISM 
 
Introduction 
 
The balance of positive and negative growth signals is critical to proper neuronal 
wiring during development and effective regeneration following injury.  Of particular 
interest to the regeneration field is the characterization of inhibitory cues and 
signaling pathways that prevent axonal outgrowth in the CNS following injury.  
Several axonal signals have been identified downstream of growth repulsive cues 
including Rho GTPase, Cdk5, PKC, calcium and PTEN (Hou et al., 2008).  Our 
results from Chapter II indicate that in addition to Rho and its effector ROCK, MAG 
utilizes additional signals in cortical neurons to prevent neurite outgrowth.  We 
considered a role for PTEN, previously shown to negatively regulate axonal 
outgrowth in vitro and in vivo, in MAG mediated inhibition. 
 
Biochemistry and function of PTEN 
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a lipid 
phosphatase and tumor suppressor that regulates numerous crucial biological 
processes including cell survival, proliferation, growth, chemotaxis, polarity, 
angiogenesis and migration (Endersby and Baker, 2008; Keniry and Parsons, 2008).  
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Mutations in PTEN are associated with many types of human cancers, including 
prostate, breast, and brain.  Furthermore, PTEN plays an important role in nervous 
system development.  The PTEN hamartoma tumor syndromes, which include 
Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome, are associated with 
germline PTEN mutations.  In addition to multiple hamartomas, clinical 
manifestations of these syndromes include increased intracranial pressure, seizures, 
ataxia, learning deficits, and autistic behavior.  Many of these symptoms have been 
attributed to neuronal abnormalities such as increased neuronal size, defects in 
neuronal migration, and irregular synapses (Endersby and Baker, 2008). PTEN 
mutations have also been identified in individuals with autism spectrum disorders 
(Goffin et al., 2001; Butler et al., 2005).       
PTEN is a 47kDA protein that can generally be subdivided into a catalytic N-terminal 
domain and a regulatory C-terminal domain (Knobbe et al., 2002) (Figure 3.1a).  The 
N-terminal domain is homologous to tensin and auxilin and contains the 
phosphatase domain, with activity towards both phosphoinositides and 
phosphoproteins.  The C-terminal domain is important for the regulation of PTEN 
(Georgescu et al., 1999; Lee et al., 1999; Knobbe et al., 2002).  The C2 domain 
mediates lipid binding of PTEN, thus enabling the interaction of PTEN with the cell 
membrane.  The C-terminus also contains two PEST sequences, which are 
important for controlling the stability and degradation of PTEN, and a PDZ-binding 
motif, which facilitates the interaction of PTEN with various PDZ domain-carrying 
proteins, also important for PTEN function and stability.  Finally, PTEN contains 
various phosphorylation sites in its C-terminus.  Phosphorylation of PTEN can
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Figure 3.1.  PTEN structure and function.  A, A schematic of PTEN, showing the N-
terminal catalytic domain and C-terminal regulatory domain.  The N-terminal domain 
of PTEN contains its phosphatase function.  The C-terminal domain includes several 
elements implicated in regulating PTEN stability and function.  B, A model of PI3K/Akt 
regulation by PTEN is shown.  While PI3K phosphorylates PIP2 to PIP3, PTEN 
antagonizes PI3K function by reversing that process and converting PIP3 to PIP2.  
One of the primary downstream targets of PI3K is Akt.  Akt is recruited to PIP3 at the 
plasma membrane and is phosphorylated by several kinases including PDK-1 and 
mTORC2.  Several biological processes are regulated by PI3K/Akt and thus by PTEN 
due to its crucial role as a negative regulator of PI3K signaling.  Adapted from 
Knobbe et al. 2002 and Yang et al. 2009. 
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Proliferation 
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Motility 
Polarity 
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A 
  79 
 
enhance or prevent its degradation by the proteasome, depending on which sites are 
phosphorylated (Torres and Pulido, 2001; Leslie et al., 2008) 
The main function of PTEN is to antagonize the PI3K/Akt pathway (Leslie and 
Downes, 2002) (Figure 3.1b).  Phosphatidylinositol-3-kinase (PI3K) is recruited to 
receptors, such as receptor tyrosine kinases in response to various growth factors.  
At the membrane, one of the most prominent roles of PI3K is the phosphorylation of 
phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-
triphosphate (PIP3) (Engelman et al., 2006).  One of the major downstream proteins 
activated by PI3K is Akt, a serine-threonine kinase that is recruited to PIP3 at the 
plasma membrane via its pleckstrin homology domain.  Akt is then activated through 
phosphorylation by various kinases including phosphoinositide-dependent kinase 1 
(PDK1) (also a PI3K target) (Alessi et al., 1997) and mTORC2 (Sarbassov et al., 
2005).  Akt is a critical regulator of many cellular functions including promotion of cell 
survival, increasing cell proliferation, and increasing cell size (Manning and Cantley, 
2007; Keniry and Parsons, 2008).  PTEN is a phosphatase for PIP3, converting it to 
PIP2 and thus down regulating Akt signaling (Maehama and Dixon, 1998).  PTEN is 
crucial to controlling PI3K signaling and disruption of PTEN function, resulting in the 
deregulation of PI3K/Akt, has severe consequences in vivo as evidenced by 
emergence of tumors with PTEN mutations and the early embryonic lethality in 
PTEN knockout mice.  
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PTEN in neurite outgrowth inhibition 
PTEN plays an important role in the development and maintenance of the nervous 
system.  PTEN is ubiquitously and highly expressed in the brain during embryonic 
development and remains expressed in the adult (Luukko et al., 1999; Gimm et al., 
2000).  PTEN regulates neuron cell size, neuronal precursor proliferation, and 
process (dendrite and axon) branching (Groszer et al., 2001; Kwon et al., 2001; 
Marino et al., 2002; Kwon et al., 2006; van Diepen and Eickholt, 2008).  A great deal 
of what we know about PTEN’s function in the brain has come from studies with 
conditional PTEN knockout mice (Table 3.1).  Deletion of PTEN in neural stem cells 
by crossing PTEN floxed mice with nestin promoter-driven Cre mice resulted in 
marked changes in brain morphology such as enlarged brains and layering defects 
throughout the brain, including the cortex and cerebellum (Groszer et al., 2001).  
These gross changes were attributed to increased neuronal size and number (due to 
decreased apoptosis and increased proliferation) and likely defects in migration. 
PTEN was deleted from differentiated cortical and hippocampal neurons by crossing 
PTEN floxed mice with Neuron specific enolase-Cre mice (Kwon et al., 2006).  
Similar to the above study, these mice exhibited macrocephaly as a result of 
neuronal hypertrophy. In this study, the effect of PTEN knockout on neurons with 
established neuronal processes was analyzed.  Most notably, the neurons from 
these mice had thickened or elongated processes, ectopic processes and increased 
synapses.  Perhaps as a result of these neuronal defects, PTEN null mice showed 
abnormalities in social interaction and learning similar to autism spectrum disorders. 
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Effects of PTEN deletion on brain development  
Table 3.1 
Groszer et al., 2001 
Reference 
!"#$%&"'()*+',&#"'&%'#-./'0112'
Marino et al., 2002 
Kwon et al., 2001 
Backman et al., 2001 
Kwon et al., 2006 
Marino et al., 2002 
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There is growing evidence that both PI3K/Akt and PTEN play an important role in the 
regulation of neurite outgrowth, with the PI3K/Akt pathway promoting neurite 
outgrowth and PTEN negatively regulating it (Hou et al., 2008; Read and Gorman, 
2009; Park et al., 2010b).  The role of PI3K/Akt as a positive modulator of neurite 
outgrowth has been shown in various populations of PNS and CNS neurons.  Axon 
outgrowth in response to numerous growth factors, for example, depends on PI3K 
and Akt signaling.  Overexpression of constitutively active AKT in neurons increased 
dendritic lengths (Zheng et al., 2008) or axonal caliber (Markus et al., 2002).  
Interestingly, a function for Akt in axon regeneration in vivo was shown in motor 
axons, where constitutively active Akt overexpression in these neurons promoted 
axon regeneration following axotomy (Namikawa et al., 2000).    
A role for PTEN has been demonstrated downstream of extrinsic cues in the 
regulation of neurite outgrowth.  PTEN was identified downstream of Sema3A 
mediated growth cone collapse in sensory neurons. Stimulation of PI3K signaling by 
a peptide activator of the kinase or through expression of a dominant negative PTEN 
lacking its phosphatase function resulted in attenuation of Sema3A induced growth 
cone collapse (Chadborn et al., 2006).  Sema3A reduced levels of phosphorylated 
Akt in neuroblastoma cells, a change that required functional PTEN, suggesting that 
Sema3A utilizes PTEN to modulate Akt activity in growth cone collapse. PTEN can 
also negatively regulate neuronal branching and arborization.  Overexpression of 
PTEN in the developing retina resulted in a dramatic decrease in the quantity of 
branched axons as well as the number of branches (Drinjakovic et al., 2010).  There 
is also evidence that PTEN is negatively regulated to promote axon outgrowth in 
response to NGF.  In cultured hippocampal neurons, NGF activates CK2 to 
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phosphorylate and inactivate PTEN and thus promote neurite outgrowth (Arevalo 
and Rodriguez-Tebar, 2006). Furthermore, NGF induced differentiation of PC12 cells 
to a neuronal phenotype, which includes the development of neurites, was blocked 
with PTEN over-expression (Musatov et al., 2004).       
Park et al. (2008) postulated that the growth impeding properties of PTEN might 
come into play in inhibition of axon regeneration.  They demonstrated a role for 
PTEN as a negative regulator of CNS axon regeneration following injury in vivo.   
Deletion of PTEN in retinal ganglion cells resulted in significant axon outgrowth, past 
the injury site, following optic nerve injury (Park et al., 2008) (Figure 3.2).  PTEN may 
be an intrinsic negative regulator of axon regeneration (Park et al., 2008; Park et al., 
2010b).  However, evidence for PTEN’s function in response to positive and 
negative extracellular signals in axon outgrowth regulation (see above) suggest that 
PTEN may be modulated by inhibitory proteins in axonal injury to prevent regrowth.  
We postulated that PTEN is involved in MAG mediated inhibition of cortical neuron 
outgrowth.  We found that knockdown of PTEN by shRNA or by neuronal specific 
knockout resulted in significant, although partial reversal of outgrowth inhibition by 
MAG.  Overexpression of consitutively active Akt in cortical neurons also reduced 
their susceptibility to MAG inhibition.  Furthermore, we found that MAG reduced 
levels of phosphorylated Akt in cortical neurons, suggesting that MAG may activate 
PTEN and thus inhibit Akt-mediated axonal outgrowth.  
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Figure 3.2.  PTEN is a negative regulator of axon regeneration in vivo.  PTEN 
floxed mice were injected in the eye with an adenovirus expressing Cre for A, 14 
days or B, 28 days or a control GFP expressing adenovirus for C, 14 days or D, 28 
days following optic nerve injury.  Optic nerves were labeled with cholera toxin B 
(CTB).  Significant growth of retinal ganglion cell axons was observed past the injury 
site (*) with PTEN knockout (A) and (B).  (Park et al. 2008).     
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Experimental Procedures 
Primary neuron cultures 
Cortical neurons were isolated at E15-E17, dissociated in 0.06% trypsin 
(Worthington) for 30 min at room temperature, triturated and plated in Neurobasal 
media with B27 supplement on dishes coated with 2 µg/ml laminin (Invitrogen) or on 
CHO cells for neurite outgrowth assays. 
 
Immunostaining  
Cells were fixed in 3.7% formalin, blocked with 10% normal goat serum in PBS 
containing 0.2% triton X-100, incubated with primary antibody overnight and 
visualized with fluorescently labeled secondary antibodies and mounted with 
medium containing DAPI (Vectashield, Vector Labs).  Primary antibodies used: anti-
PTEN (1:100, Cell Signaling), anti-TuJ1 (1:500, Covance) and chicken anti-GFP for 
enhancement of GFP fluorescence (1:500, Ambion).  Secondary antibodies used: 
Rhodamine conjugated donkey anti-rabbit (1:300, Jackson ImmunoResearch), goat 
anti-mouse Alexa 488 (1:500, Invitrogen), Rhodamine conjugated donkey anti-
mouse (1:400, Jackson ImmunoResearch) and Cy2 conjugated donkey anti-chicken 
(1:200, Jackson ImmunoResearch).   
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Neurite outgrowth assays  
Neurite outgrowth assays on MAG transfected CHO cells have been previously 
described (Mukhopadhyay et al., 1994).  Cortical neurons or CGNs (40,000/well) 
were plated on confluent monolayers of MAG-CHO or control CHO cells in 8 well 
tissue culture slides (Lab-Tek, Nalge Nunc International).  After incubation for ~20 
hrs, co-cultures were fixed and immunostained with anti-TuJ1, as described above.  
Where indicated, cell permeable C3 exoenzyme (1µg/ml, Cytoskeleton, CT04) was 
added at the time of neuronal plating.  The percent of neurons with neurites was 
quantified in a blinded manner using a Zeiss fluorescence microscope at 40x 
magnification.  A neurite was defined as a process at least twice the length of the 
cell body. For each experiment, 2-4 wells were used for each condition and at least 
250 neurons were counted per condition.  Neurite lengths were determined using 
ImageJ software analysis of images taken with a Zeiss fluorescence microscope at 
40x magnification.  The longest neurite  ≥1 cell body was measured for each neuron, 
with at least 145 neurites evaluated for each experimental condition. 
 
Mice  
CD1 mice (Charles River), EMX1-Cre mice (Iwasato et al., 2000) or PTEN floxed 
mice (Jackson Laboratory) (Groszer et al., 2001) were used, as indicated.  All 
experiments with animals were approved by the Animal Care and Use Committee at 
Vanderbilt University. 
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Neuronal transfections  
Cortical neurons were co-transfected with GFP (pEGFP, Clontech) (1 µg) and 
control shRNA (5 µg) or PTEN shRNA (5 µg; in pSUPER.retro.puro; generously 
provided by C. Arteaga, Vanderbilt University, Nashville, TN (Miller et al., 2009)), or 
with GFP and myristoylated Akt (Myr-Akt; in pUSE; kindly provided by W. Pao, 
Vanderbilt University, Nashville, TN) or control vector by electroporation with an 
Amaxa Nucleofactor device according to the manufacturer’s protocol.  Cells were 
plated on laminin-coated dishes and re-fed at 24 hrs post-transfection.  The neurons 
were incubated 48 hrs to allow for PTEN knockdown or Myr-Akt expression, then 
they were incubated in trypsin and dispase and gently lifted with a cell lifter.  
Neurons were spun down and resuspended in Neurobasal/B27.  10,000 
neurons/well were plated on 8-well slides containing confluent monolayers of CHO 
or MAG-CHO cells in Neurobasal/B27.  Twenty hours after plating, cells were fixed 
and immunostained for TuJ1 and GFP and analyzed for neurite outgrowth.  The 
remaining neurons were collected for Western blot analysis or replated on a laminin 
coated 8-well slide for immunostaining to verify PTEN knockdown.  Myr-Akt 
expression was confirmed by Western blot.  For analysis of the percent of neurons 
with neurites, 3-4 wells were counted per condition in a blinded manner for each 
experiment and a minimum of 800 neurons total were counted per experimental 
condition.  Replicate wells, with at least 145 total neurites measured per 
experimental condition, were evaluated in a blinded fashion for neurite length. 
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FACS isolation of neurons   
Cortical neurons isolated from E15 to E17 mice were labeled with calcein  (2 nM 
PBS) (Invitrogen, Molecular Probes) for 30 min with gentle rotation at room 
temperature, washed with PBS and incubated in PBS at room temperature for an 
additional 30 min. The labeled neurons (5 x 106) were resuspended in 
Neurobasal/B27 and plated on a confluent monolayer of MAG-CHO or control CHO 
cells in 6 cm dishes. After 2-4 hrs, the cells were washed twice with ice cold PBS to 
remove non-adhered neurons and then harvested by gentle scraping. The cells were 
re-suspended in PBS and passed through a cell strainer (BD Falcon, 40µm nylon) to 
remove cell clumps. The calcein labeled neurons were collected by FACS using a 
BD FACS Aria cell sorter.  Reanalysis of sorted cells verified that only calcein 
labeled cells were collected.  The sorted neurons were lysed and subjected to 
Western blot analysis as indicated.  For control experiments involving BDNF 
treatment, the cells were treated with 100 ng/ml BDNF for 10 min prior to harvesting 
for FACS analysis.  Recombinant BDNF was generously provided by Regeneron, 
Inc. 
 
Western blot analysis   
Cells were lysed in NP40 lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% 
NP-40, 10% glycerol) containing a protease inhibitor cocktail (Complete Mini, 
Roche).  For experiments analyzing phosphorylated proteins, 1 mM sodium 
orthovanadate, 1 mM sodium fluoride, and 1 mM β-glycerophosphate were added to 
the lysis buffer. Cell lysates were subjected to SDS-PAGE and Western blotting 
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using anti-Akt (1:1000, Cell Signaling), anti-phospho-Akt (Ser483) (1:1000, Cell 
Signaling), anti-PTEN (1:1000, Cell Signaling), anti-TuJ1 (1:1000, Covance) or 
mouse anti-GFP (1:1000, Roche).  Secondary antibodies conjugated to horse radish 
peroxidase included anti-rabbit (1:3000, Thermo Scientific) and anti-mouse (1:3000, 
Promega).  For FACS collected neurons, the Odyssey infrared imaging system 
(Licor) was used for Western blot analysis and quantification according to the 
manufacturer’s protocol.  Secondary fluorescent antibodies used for Odyssey were 
IRDye goat anti-mouse 800 and goat anti-rabbit 680 (Licor).     
 
Results 
 
Knockdown or genetic deletion of PTEN partially reverses neurite outgrowth 
inhibition by MAG 
Numerous signal transduction pathways have been implicated in the regulation of 
neurite outgrowth (Hou et al., 2008). We tested inhibitors of several of these 
pathways for their ability to reverse the effects of MAG: SP600125, a c-Jun N-
terminal kinase inhibitor, BIO/Inhibitor IX, an inhibitor of GSK3, Roscovitine, which 
targets cdk5, and the Src-family kinase inhibitor PP2.  However, we did not observe 
any notable rescue (data not shown). We were also interested in evaluating a 
possible role for PTEN (Phosphatase and tensin homologue deleted on 
chromosome 10), since it was recently reported that deletion of this phosphatase 
resulted in considerable regeneration of retinal ganglion cell axons following optic 
nerve injury (Park et al., 2008). To determine whether MAG signals through PTEN to 
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Figure 3.3.  PTEN knockdown in cortical neurons partially reverses neurite 
outgrowth inhibition by MAG. Cortical neurons were electroporated with GFP and 
control shRNA or PTEN shRNA and plated on laminin-coated dishes for 72 hrs to 
allow for optimal PTEN knockdown.  A, At 72 hrs, neurons were lysed and analyzed 
by Western blot or, B, replated and 20 hrs later fixed and immunostained for PTEN to 
verify PTEN knockdown or, C and D, replated on control CHO or MAG-CHO cells for 
neurite outgrowth analysis. The cells were fixed 20 hrs after plating and 
immunostained for Tuj1.  Neurite outgrowth was analyzed by counting the percentage 
of GFP+ neurons with neurites (C) (n=4) or measuring neurite lengths of GFP+ 
neurons (D) (n=3).  Data represent mean ± SEM  (*, p<0.05, **, p<0.01, ***, p<0.001 
by two way ANOVA).  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negatively regulate neurite outgrowth we first evaluated the effect of PTEN 
knockdown. Cortical neurons were co-transfected with GFP and a control shRNA or 
PTEN shRNA and plated on laminin for 72 hours to allow for efficient PTEN 
knockdown, at which point they were replated onto MAG-CHO cells or control CHO 
cells.  PTEN knockdown was confirmed by Western blot analysis of neurons 
collected after 72 hours (Figure 3.3a) and immunostaining of replated neurons 
(Figure 3.3b).  Approximately 98% of GFP+ neurons co-transfected with PTEN 
shRNA had decreased PTEN staining. Interestingly, knocking down PTEN 
significantly restored neurite outgrowth in neurons plated on the MAG-CHO cells (a 
20.2% increase in the percent of neurons with neurites and a 22.7% increase in the 
average neurite length relative to neurons on control CHO cells), although there was 
not a complete recovery to control levels (Figure 3.3c and Figure 3.3d). It is 
important to note that reducing PTEN did not affect neurite outgrowth when the 
neurons were plated on control CHO cells (Figure 3.3c and Figure 3.3d). These 
results suggested that PTEN contributes to the growth inhibitory signal elicited by 
MAG. 
To further establish a role for PTEN in MAG mediated inhibition of neurite outgrowth, 
we evaluated the effect of genetically deleting pten in cortical neurons.  Mice 
expressing Cre recombinase under an EMX1 promoter (Iwasato et al., 2000) were 
crossed with pten floxed mice (Groszer et al., 2001).  PTEN knockout was confirmed 
in cortical neurons by Western blot analysis of cultured neurons (Figure 3.4a).  
Embryonic EMX1-Cre;pten+/+, WT;ptenfl/fl or EMX1-Cre; ptenfl/fl cortical neurons were 
plated on control CHO or MAG-CHO cells for 20 hours.  A significant increase in the 
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Figure 3.4.  PTEN knockout cortical neurons are less susceptible to inhibition 
by MAG. A, Lack of PTEN expression in EMX1-Cre;ptenfl/fl neurons was confirmed by 
Western blot analysis of cortical neuron culture lysates.  B and C, EMX1-Cre;pten+/+, 
wildtype;ptenfl/fl  or EMX1-Cre;ptenfl/fl (pten-/-) embryonic neurons (E17) were plated 
on control CHO or MAG-CHO cells in the presence or absence of C3 exoenzyme 
(1µg/ml) and subsequently fixed and immunostained for Tuj1. No difference was 
observed between the EMX1-Cre;pten+/+ and the wildtype;ptenfl/flneurons; therefore 
the data were combined and are labeled as pten+/+. Neurite outgrowth was 
evaluated by determining the percent of neurons with neurites (B) or measuring 
neurite lengths (C).  Data represent mean ± SEM (n=3, *, p<0.05, **, p<0.01, ***, 
p<0.001 by two way ANOVA).  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neurons on MAG-CHO cells compared to EMX1-Cre;pten+/+ or WT;ptenfl/fl neurons 
(Figure 3.4b and Figure 3.4c).   Interestingly, when pten null cortical neurons were 
treated with C3 exoenzyme, neurite outgrowth on MAG-CHO cells was not 
significantly different from that on control CHO cells (Figure 3.4b and Figure 3.4c).  
The additive effect of PTEN knockout and Rho inactivation suggests that both 
molecules contribute to inhibition of cortical neurite outgrowth by MAG, likely acting 
through different pathways.          
 
Overexpression of constitutively active Akt in cortical neurons significantly reverses 
MAG inhibition of neurite outgrowth  
One of the primary biological functions of PTEN is to counteract phosphatidylinositol 
3-kinase (PI3K) by de-phosphorylating phosphatidylinositol 3,4,5-trisphosphate 
(PIP3), thereby inhibiting activation of the downstream kinase Akt.  As expected, we 
observed an increase in phosphorylated Akt in neurons transfected with PTEN 
shRNA (Figure 3.5a).  To further establish a role for PTEN downstream of MAG, we 
assessed the effect of expressing an activated form of Akt, by-passing the effects of 
PTEN. A myristoylated form of Akt (myr-Akt) was transfected into cortical neurons 
and neurite outgrowth on MAG-CHO cells was compared to that on control CHO 
cells.  The activation of Akt by the expression of myr-Akt was confirmed by an 
increase in the phosphorylated form of the enzyme (Figure 3.5b).  Cortical neurons 
were co-transfected with GFP and myr-Akt or a control vector and 72 hours later, the 
neurons were replated on control CHO or MAG-CHO cells for twenty hours. When 
transfected with myr-Akt, there was a significant, 24.4% increase in the percent of
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Figure 3.5.  Expression of constitutively active AKT in cortical neurons reverses 
the inhibition of neurite outgrowth by MAG.  A, Cortical neurons were 
electroporated with control shRNA or PTEN shRNA, cultured for 72 hrs, then 
subjected to Western blot analysis for levels of PTEN, phospho-AKT and AKT.  B, 
Cortical neurons were electroporated with control vector or myr-AKT and 72 hrs later 
lysed and the level of phospho-AKT and total AKT analyzed by Western blot.  C and 
D, Cortical neurons were electroporated with GFP and control vector or myr-AKT and 
plated on laminin-coated dishes for 72 hrs at which point they were replated on 
control CHO or MAG-CHO cells.  The neurons were fixed 20 hr after plating, 
immunostained for Tuj1 and neurite outgrowth was analyzed by counting the 
percentage of GFP+ neurons with neurites (C) or determining neurite lengths of 
GFP+ neurons (D).  Data represents mean ± SEM (n=3, *, p < 0.05, **, p<0.01, ***, 
p<0.001 by two way ANOVA).  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neurons with neurites on MAG-CHO cells relative to neurons transfected with a 
control vector (Figure 3.5c).  A similar 23.8% increase in average neurite length was 
observed for neurons expressing myr-Akt on MAG-CHO cells compared to control 
transfected cells (Figure 3.5d).  These results indicate that preventing activation of 
PTEN by expressing active Akt can reverse the inhibition of neurite outgrowth by 
MAG. 
 
MAG reduces levels of phosphorylated Akt in cortical neurons 
Finally, to demonstrate that PTEN is regulated by MAG, we assessed the activity of 
Akt in neurons plated on MAG-CHO cells. If MAG activates PTEN, then the level of 
phospho-Akt should be reduced. We were specifically interested in the response of 
the neurons to membrane-bound MAG; therefore, the neurons were plated on MAG-
CHO cells or control CHO cells for 2 - 4 hours, then isolated by fluorescence-
activated cell sorting (FACS) and the level of phospho-Akt measured by Western 
blot.  To separate neurons from CHO cells, the neurons were labeled with calcein 
dye prior to plating.  Reanalysis of collected cells confirmed that only calcein positive 
cells were collected (Figure 3.6a).  Sorted cells were lysed and subjected to Western 
blot analysis for TuJ1 expression and levels of phosphorylated Akt.  To verify that 
this method reliably detected changes in Akt phosphorylation and that the 
phosphorylation was not reversed during the sorting protocol, the neurons on control 
CHO cells were treated with BDNF, which is known to increase Akt phosphorylation 
in cortical neurons (Hetman et al., 1999).  We consistently detected an increase in 
phosphorylated Akt following BDNF treatment (Figure 3.6b and Figure 3.6c).  
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Figure 3.6.  MAG reduces AKT phosphorylation in cortical neurons. Cortical 
neurons were labeled with calcein, plated on control or MAG expressing CHO cells 
for 2-4 hr, and then subjected to FACS to isolate the neurons from the CHO cells. A, 
The isolation of neurons from CHO cells using calcein labeling was confirmed by 
reanalysis of the sorted cells. The left panel depicts unlabeled neurons (green) plated 
on CHO cells (orange), which can be roughly differentiated from each other based on 
side scatter and forward scatter differences.  The central panel shows calcein-labeled 
neurons plated on CHO cells. The small peak for CHO cells at higher fluorescence 
intensity in the central panel is likely neuron doublets.  The right panel depicts 
fluorescent cells that were collected by FACS, then reanalyzed to verify that 
fluorescent negative cells were excluded. B, Following FACS, neurons that had been 
plated on control CHO or MAG-CHO were lysed and analyzed by Western blot for 
phospho-AKT, total AKT, and TuJ1 expression (to further confirm neuronal isolation 
and as a loading control). BDNF treated or untreated neurons plated on control CHO 
cells and isolated by FACS served as a control for the experimental method. C, 
Quantitative analysis of the ratio of phospho-AKT to total AKT. Values were 
normalized to untreated neurons plated on control CHO cells. Data represents mean 
± SEM (n=5, * p = 0.0005, based on Student’s t-test).    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Importantly, we also found that neurons plated on MAG-CHO cells had significantly 
reduced levels of phosphorylated Akt compared to those plated on control CHO cells 
(Figure 3.6b and Figure 3.6c).  Taken together, these results reveal a novel 
mechanism by which MAG inhibits cortical neurite outgrowth through inhibition of the 
PI3K/Akt pathway. 
 
Discussion 
We identified PTEN as an essential component of MAG’s inhibitory effects on neurite 
outgrowth in cortical neurons. PTEN is a lipid phosphatase that indirectly inactivates 
the kinase Akt by reducing the levels of phosphatidylinositol 3,4,5 trisphosphate, 
which is required for Akt activation. A previous study suggested that the 
PI3K/Akt/mTOR pathway promotes axon extension and demonstrated that deletion 
of PTEN or the mTOR repressor, Tuberous sclerosis complex 1 (TSC1), significantly 
improved regeneration in the optic nerve following a crush injury (Park et al., 2008). 
Here, we demonstrated that membrane-bound MAG actively reduced Akt 
phosphorylation, thereby implicating activation of PTEN by this inhibitor. 
Suppression of Akt activity would decrease activation of Rac, a GTP binding protein 
that promotes neurite extension through regulation of actin polymerization, and 
increase the activation of Glycogen synthase kinase 3 (GSK3), a kinase that 
regulates microtubule dynamics (Park et al., 2010b). Similar to our findings, PTEN 
was identified as a target of Sema3A in triggering growth cone collapse of sensory 
neurons (Chadborn et al., 2006). Thus, PTEN appears to be a key component in 
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another signal transduction pathway, like the Rho/ROCK cascade, that is activated 
by inhibitors of axon growth.  
The mechanisms by which PTEN is regulated are not well understood. It can be 
serine/threonine phosphorylated by CK2 and GSK3, a modification that inhibits its 
activity, reduces membrane localization and/or causes destabilization of the protein 
(Leslie et al., 2008).  NGF increases PTEN phosphorylation by CK2 in hippocampal 
neurons, thereby promoting axonal growth (Arevalo and Rodriguez-Tebar, 2006). 
Reactive oxygen species generated in response to various growth factors can also 
suppress PTEN activity by causing the formation of disulfide bonds (Lee et al., 2002; 
Leslie et al., 2003; Kwon et al., 2004; Seo et al., 2005). In contrast, the recruitment 
to membranes by increasing the local concentration of acidic lipids, such as 
phosphatidylinositol 3,4 bisphosphate, can activate PTEN (Campbell et al., 2003; 
Iijima et al., 2004; Redfern et al., 2008). How MAG or Sema3A modulate PTEN 
activity is not known, but Sema3A induced a local accumulation of PTEN at the 
growth cone, leading to a depletion of phosphatidylinositol 3,4,5 trisphosphate 
(Chadborn et al., 2006).  Determining the mechanisms by which MAG activates 
PTEN will be an interesting topic for future studies.  
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CHAPTER IV 
 
TRAF6 IS REQUIRED FOR NEURITE OUTGROWTH INHIBITION BY  
SOLUBLE MAG 
 
Introduction 
We demonstrated in Chapter 2 that p75 is not involved in mediating signaling by 
membrane bound MAG.  However, p75 is a key mediator of neurite inhibition in 
response to soluble MAG (Wong et al., 2002; Yamashita et al., 2002; Yamashita and 
Tohyama, 2003).  Pathways downstream of NgR-p75/TROY-LINGO1 that result in 
neurite outgrowth inhibition and Rho GTPase regulation remain poorly understood.  
There is evidence for p75 cleavage in MAG mediated outgrowth inhibition and Rho 
activation (Domeniconi et al., 2005); however, how receptor processing influences 
Rho activity is not clear. An interaction between p75 and RhoGDI has been 
implicated in MAI signaling (Yamashita and Tohyama, 2003).  By binding to Rho-
GDI, p75 causes the release and activation of Rho.  There is also evidence that 
Kalirin9, a Rho guanine nucleotide exchange factor (RhoGEF), is released from p75 
upon addition of MAG to allow Rho GDI binding and to enhance Rho activation 
(Harrington et al., 2008).   
Much of what is known about p75 signaling arises from studies of the role of p75 in 
neurotrophin mediated neuronal apoptosis or survival.  The intracellular domain of 
p75 contains no intrinsic enzymatic activity (Bradley and Pober, 2001) and as such 
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requires adaptor proteins to transduce ligand mediated signaling intracellularly.  
Tumor necrosis factor Receptor Associated Factor 6 (TRAF6) has emerged as an 
important signaling molecule downstream of p75 and other TNFR family members 
(Ha et al., 2009).  TRAF6 is a 60kDa E3 ligase and adaptor protein that participates 
in various physiological processes including immunity, bone morphogenesis, and 
neuronal survival/apoptosis (Chung et al., 2002; Wu and Arron, 2003).  As an E3 
ubiquitin ligase, TRAF6 attaches an ubiquitin chain through lysine 63 to its 
substrates and to itself.  This modification does not target substrates for degradation 
but functions as a protein-protein interaction motif that can direct the formation of 
multi-protein complexes involved in the regulation of various kinase cascades, 
including IkB, MAPK, and c-Src (Wong et al., 1999; Wang et al., 2001; Wu and 
Arron, 2003).  As an adaptor protein, TRAF6 plays an important role as a proximal 
signal transducer mediating the activation of signaling pathways initiated by receptor 
engagement.  As an example, TRAF6 was recently identified as an E3 ligase for Akt.  
In mouse embryonic fibroblasts treated with insulin-like growth factor 1 (IGF-1), 
TRAF6 ubiquitinated Akt and mediated its membrane recruitment and subsequent 
phosphorylation (Yang et al., 2009).  As a signaling intermediate for p75, TRAF6 
was recruited to the receptor upon neurotrophin binding (Khursigara et al., 1999) and 
was required for the subsequent activation of NF-kB and JNK, which play an 
important role in neuronal survival and apoptosis respectively (Yeiser et al., 2004).   
We hypothesized that TRAF6 is also an important mediator of signaling events 
downstream of NgR-p75/TROY-LINGO1 in the process of neurite outgrowth 
regulation.  TRAF6 is involved in p75 and TROY signaling in other contexts (Kojima 
et al., 2000; Naito et al., 2002; Ohazama et al., 2004; Yeiser et al., 2004), making it 
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an attractive candidate as a signal transducing intermediary for the classic NgR 
complex.  Furthermore, TRAF6 has been implicated in cytoskeletal regulation.  
During bone resorption, TRAF6 and c-Src function together to regulate the 
cytoskeletal changes required for osteoclast differentiation (Armstrong et al., 2002; 
Nakamura et al., 2002; Wang et al., 2006).  We postulated that TRAF6 might also 
play a role in the cytoskeletal changes necessary for axon outgrowth inhibition 
downstream of MAIs.  We found that TRAF6 is required for neurite outgrowth 
inhibition by soluble MAG.  We also identified an interaction between TRAF6 and 
p21-activated kinase (PAK), a protein known to regulate the cytoskeleton.  
Furthermore, we found that overexpression of NgR decreased the interaction 
between p75 and TRAF6, which might be an important step in the role of TRAF6 in 
neurite outgrowth regulation.  
 
Experimental procedures 
Primary neuron cultures 
Cerebellar granule neuron (CGN) cultures were prepared from postnatal day 4-7 
mice.  Cerebella were isolated, dissociated in 0.125% trypsin (Worthington) at 37oC 
for 15 min, washed in PBS, triturated and subsequently plated in Neurobasal media 
(Gibco) containing B27 supplement (Gibco), 25 mM KCl, 33 mM dextrose, 2 mM 
glutamine, and 100 U/ml penicillin / 100 µg/ml streptomycin (Gibco).  CGNs were 
plated on CHO cells or poly-L-ornithine (Sigma) coated dishes for neurite outgrowth 
assays.  Cortical neurons were isolated at P1-P3, dissociated in 0.06% trypsin 
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(Worthington) for 30 min at room temperature, triturated and plated in Neurobasal 
media with B27 supplement on CHO cells for neurite outgrowth assays. 
 
Neurite outgrowth assays  
Neurite outgrowth assays on MAG transfected CHO cells have been previously 
described (Mukhopadhyay et al., 1994).  Cortical neurons or CGNs (40,000/well) 
were plated on confluent monolayers of MAG-CHO or control CHO cells in 8 well 
tissue culture slides (Lab-Tek, Nalge Nunc International).  Neurite outgrowth assays 
with soluble MAG were conducted with CGNs.  40,000 CGNs were plated on poly-L-
ornithine coated 8 well tissue culture slides in the presence of MAG-Fc (25 µg/ml) 
(provided by Marie Filbin) or control IgG (25 µg/ml).  After incubation for ~20 hrs, co-
cultures were fixed and immunostained with anti-TuJ1 (1:500, Covance).  The 
percent of neurons with neurites was quantified in a blinded manner using a Zeiss 
fluorescence microscope at 40x magnification.  A neurite was defined as a process 
at least twice the length of the cell body.  
 
Mice 
CD1 mice (Charles River) and 129 mice with the Traf6 gene deleted (Naito et al., 
1999) were used, as indicated.  All experiments with animals were approved by the 
Animal Care and Use Committee at Vanderbilt University. 
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Co-immunoprecipitation experiments 
HEK293 cells, maintained in DMEM with 10% fetal bovine serum, were transfected 
with constructs expressing FLAG (in CMV-1), FLAG-TRAF6 (in pRK5), myc-PAK (in 
CMV-6) or FLAG-NgR1 using Lipofectamine (Invitrogen) according to the 
manufacturer’s protocol.  Cells were harvested 48 hrs after transfection and lysed in 
NP40 lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 10% glycerol) 
for TRAF6 and PAK co-immunoprecipitation or RIPA buffer (50 mM Tris pH 8.0, 150 
mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS) for p75 and TRAF6 co-
immunoprecipitation, both containing a protease inhibitor cocktail (Complete Mini, 
Roche).  2-4 mg of cleared lysates were utilized for immunoprecipitation 
experiments.  2 µg of anti-FLAG or 5 µl of anti-p75 (generated from a GST fusion 
protein with the p75NTR intracellular domain) were added to lysates, which were 
incubated overnight with rotation at 4oC.  30 µl of Protein A Sepharose slurry 
(Invitrogen) was added to lysates and samples were incubated with rotation at 4oC 
for 1 hr.  Beads were centrifuged at 1,000 rpm for 1 min and washed 3 times with 
their respective lysis buffers. 20 ml of 6x SDS loading buffer was added to each 
sample and samples subjected to SDS-PAGE and Western analysis with anti-
p75NTR (1:1000), anti-TRAF6 (1:500, Santa Cruz), anti-myc (1:500, Santa Cruz) or 
anti-FLAG (1:1000, Sigma).  Secondary antibodies conjugated to horseradish 
peroxidase included anti-rabbit (1:3000, Thermo Scientific) and anti-mouse (1:3000, 
Promega).   
Postnatal (P5-P7) mouse cerebella were collected in NP40 lysis buffer, 
homogenized with a dounce homogenizer and cleared at 12,000 rpm for 8 min.  Anti-
PAK1 (2.5  µl, Santa Cruz) or control rabbit gamma globulin (Jackson Laboratories) 
  104 
were added to 4 mg of total protein and samples incubated overnight with rotation at 
4oC.  30 µl of Protein A Sepharose slurry (Invitrogen) was added to each sample 
followed by rotation for 1 hr at 4oC.  Beads were centrifuged at 3,000 rpm for 1 min 
at 4oC and washed three times with NP40 lysis buffer.  20 ml of 6x SDS loading 
buffer was added to each sample and samples subjected to SDS-PAGE and 
Western analysis with anti-TRAF6 (1:500, Santa Cruz).  
 
GST-PAK pull-down assays 
HEK293 cells were transfected by Lipofectamine with FLAG or FLAG-TRAF6.  After 
48 hrs, cells were washed with cold TBS on ice, harvested and lysed with Lysis 
Buffer (50 mM Tris pH7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 
500 mM NaCl, 10 mM MgCl2 and protease inhibitor cocktail).  Lysates were 
centrifuged at 12,000 rpm for 4 min at 4oC and the supernatant utilized for pull-down 
assays.  40 µg of GST-PAK (attached to glutathione agarose beads) were added to 
the supernatant and samples incubated for 45 min with rotation in the cold room.  
Beads were centrifuged at 2,500 rpm at 4oC for 1 min and washed three times with 
Wash Buffer (50 mM Tris pH 7.2, 1% Triton X-100, 150 mM NaCl, 10 mM MgCl2 and 
protease inhibitor cocktail).  Beads were then subjected to SDS-PAGE and analyzed 
by Western blot with anti-TRAF6 (1:500, Santa Cruz). 
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Results 
TRAF6 is required for inhibition of neurite outgrowth by soluble but not membrane 
bound MAG 
To investigate a role for TRAF6 in neurite outgrowth inhibition by MAG we compared 
outgrowth of traf6+/+ and traf6-/- neurons in the presence of soluble MAG.  Primary 
wild-type or traf6 null cerebellar granule neurons (CGNs) were grown in the 
presence of MAG-Fc or control IgG for approximately 20 hours.  Neurons were then 
fixed, immunostained for TuJ1 and neurite outgrowth analyzed by scoring the 
percent of neurons with neurites.  MAG-Fc treatment significantly inhibited neurite 
outgrowth by decreasing the percent neurons with neurites (Figure 4.1a).  In 
contrast, traf6 null cells were not susceptible to the inhibitory effects of MAG-Fc on 
neurite outgrowth.  There were no differences in neurite outgrowth between traf6 null 
and wild-type neurons treated with control IgG (Figure 4.1b).  These results indicate 
that TRAF6 is required for the inhibitory effects of MAG and provide the first 
evidence implicating TRAF6 in neurite outgrowth inhibition.  
In order to further characterize the role of TRAF6 in the inhibition of neurite 
outgrowth by MAG signaling, we utilized CHO cells expressing MAG on the cell 
surface (MAG-CHO cells).  Surprisingly, analysis of wild-type and traf6-/- CGNs or 
cortical neurons seeded on MAG expressing CHO cells revealed no difference in 
inhibition of process outgrowth, with MAG-CHO cells inducing a similar reduction in 
the percent of neurons with neurites in both traf6+/+ and traf6-/- neurons (Figure 
4.2a and 4.2b).  Together, these findings suggest that TRAF6 is not required for 
inhibition of neurite outgrowth by surface bound MAG, but is required for the effect of 
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Figure 4.1.  TRAF6 is required for neurite outgrowth inhibition by soluble MAG. 
A, CGNs from wild-type and traf6-/- mice were grown in the presence of MAG-Fc or 
control IgG for ~20 hours and assessed for neurite outgrowth.  Neurite outgrowth is 
shown as percent of neurons with neurites relative to control treated neurons.  A 
significant decrease in neurite outgrowth is observed for wild-type but not traf6 null 
neurons with MAG-Fc treatment. (N=7)  B, There is no difference in basal neurite 
outgrowth between wild-type and knockout control treated neurons.    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Figure 4.2.  Neurite outgrowth inhibition by MAG-CHO cells does not require 
TRAF6.  Wild-type or traf6-/- postnatal A, CGNs or B, cortical neurons were plated on 
control CHO or MAG-CHO cells for ~20 hrs, at which point the cells were fixed and 
stained for TuJ1.  Neurite outgrowth was measured as the percent of neurons with 
neurites. Data is shown relative to outgrowth on control CHO cells.  No differences 
were seen in outgrowth between traf6+/+ or traf6-/- neurons on control CHO cells (not 
shown). 
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soluble MAG. Moreover, they indicate that soluble and membrane bound MAG may 
activate different signaling mechanisms to inhibit neurite outgrowth. 
 
TRAF6 interacts with PAK 
We hypothesized TRAF6 regulates Rho GTPAse signaling to mediate neurite 
outgrowth inhibition by soluble MAG.  Rho GTPAse pull-down assays were 
conducted in 293 cells over-expressing TRAF6 in an effort to detect TRAF6 
mediated changes in Rho or Rac activities.  Although those studies proved 
inconclusive (data not shown), Rac pull-down assays with GST-PAK (p21 binding 
domain from PAK) revealed that TRAF6 itself was precipitated by GST-PAK.  293T 
cells expressing FLAG or FLAG-TRAF6 were subjected to pull-down assays with 
GST-PAK and the level of TRAF6 associated with PAK analyzed by Western blot 
analysis (Figure 4.3a).  An interaction between TRAF6 and PAK was confirmed by 
co-immunoprecipitation of the two proteins from HEK293 cells (Figure 4.3b).  
Furthermore, we detected an interaction between TRAF6 and PAK endogenously by 
co-immunoprecipitation of the two proteins from cerebellar lysates (Figure 4.3c).  
The association of TRAF6 with PAK is particularly interesting since PAK is known to 
regulate several proteins that reorganize the actin-cytoskeleton, such as cofilin 
(Kreis and Barnier, 2009).    
 
The interaction between TRAF6 and p75 is decreased with NgR overexpression 
As an adaptor protein, TRAF6 is recruited to cell surface receptors upon 
engagement of the receptor with its ligand.  An interaction between p75 and TRAF6 
  109 
 
Figure 4.3.  TRAF6 interacts with PAK.   A, Pull-down assays with GST-PAK from 
TRAF6 expressing HEK293 cells followed by Western blot analysis with anti-TRAF6 
reveals a possible interaction between TRAF6 and PAK.  B, The interaction was 
confirmed by co-immunoprecipitation experiments in HEK293 cells co-expressing 
PAK and TRAF6. TRAF6 was immunoprecipitated with anti-FLAG and associating 
PAK detected with anti-Myc.  C, Co-immunoprecipitation of PAK and TRAF6 from 
cerebellar lysates.  PAK was immunoprecipitated with anti-PAK and associating 
TRAF6 analyzed by immunoblot analysis with anti-TRAF6.  Ctr = IP with gamma 
globulin. 
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has been identified in 293T cells ectopically expressing both proteins.  NGF 
treatment resulted in a significantly enhanced interaction between TRAF6 and p75 
that was dose dependent (Khursigara et al., 1999).  We co-immunoprecipitated p75 
and TRAF6 in 293 cells over-expressing these proteins as well as NgR (Figure 4.4).  
Interestingly, co-expression of the NgR consistently (N=4) caused a decrease in the 
association of TRAF6 and p75 compared to cells expressing p75 and TRAF6 alone 
(Figure 4.4).  One interpretation of this result would be that overexpression of NgR 
may mimic ligand activation and cause release of TRAF6 from the receptor, thereby 
allowing it to affect other interactors.  Unfortunately, due to the limited availability of 
active MAG-Fc we were not able to investigate the effect of MAG on the association 
of TRAF6 and p75, a question that merits future investigation. 
 
Discussion 
In an effort to elucidate signaling downstream of NgR-p75/TROY-LINGO1, we 
considered TRAF6, a signaling protein for many TNFR family members.  Our results 
indicate that TRAF6 is required for the inhibitory effects of soluble, but not 
membrane bound MAG on neurite outgrowth.  Furthermore, we identified an 
interaction between TRAF6 and PAK, a known modulator of neurite outgrowth in 
mammalian cells.  We also detected a reduction in the interaction between TRAF6 
and p75 in the presence of NgR.  These findings suggest that TRAF6 plays a role in 
the NgR-p75 mediated pathway leading to axon outgrowth inhibition, possibly 
through a functional interaction with PAK.  Due to the limited availability of active, 
functional MAG-Fc we were not able to pursue these studies further and thus were
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Figure 4.4.  The interaction between TRAF6 and p75 is decreased in the 
presence of NgR.  HEK293 cells stably expressing p75 were transfected with TRAF6 
in the presence and absence of NgR.  p75 was immunoprecipitated with anti-p75 and 
associating TRAF6 detected with anti-TRAF6 by Western blot analysis.  
Overexpression of NgR reduced the interaction between TRAF6 and p75.   
NgR +  
TRAF6 
TRAF6 + 
FLAG FLAG 
NgR +  
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not able to identify the mechanisms by which TRAF6 regulates neurite outgrowth 
downstream of MAG.  However, we feel that our findings provide important insights 
as to how TRAF6 may be functioning. 
We showed that TRAF6 is required for the inhibitory effect of soluble MAG. However 
neurons lacking TRAF6 were inhibited by membrane bound MAG similarly to wild-
type neurons.  We were initially surprised by these findings, but along with results 
presented in Chapter 2 and recent studies described in Chapter 1, these results are 
consistent with a role for NgR-p75 and TRAF6 in signaling by soluble MAG but not 
membrane bound MAG.  Our results and those of others (Chivatakarn et al., 2007; 
Mehta et al., 2007) suggest that NgR and p75 do not play an essential role in 
inhibition of neurite outgrowth by MAG-CHO cells, at least in CGNs and cortical 
neurons.  Many of the early studies demonstrating a role of p75 in neurite outgrowth 
inhibition and Rho activation by MAG (Wong et al., 2002; Yamashita et al., 2002; 
Yamashita and Tohyama, 2003) were conducted with soluble MAG.  A role for 
TRAF6 downstream of soluble MAG is consistent with these findings and suggests 
that soluble MAG and membrane bound MAG inhibit neurite outgrowth by different 
mechanisms.    
We also demonstrated that TRAF6 interacts with PAK, a serine/threonine kinase 
downstream of GTP bound Rac.  Although the regulation of PAK by MAIs has not 
yet been analyzed, the activity of its upstream activator Rac and downstream target 
Cofilin are regulated by MAIs (Niederost et al., 2002; Hsieh et al., 2006).  PAK is an 
important effector of actin reorganization in mammalian cells (Sells et al., 1997; Eby 
et al., 1998; Bokoch, 2003).  In neurons, PAK has been linked to axon guidance and 
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the promotion of neurite outgrowth (Daniels et al., 1998; Hayashi et al., 2002; Robles 
et al., 2005; Kreis and Barnier, 2009).  PAK regulates dendritic spine actin dynamics 
through its modulation of LIMK and Cofilin (Zhao et al., 2006). TRAF6 affects the 
activities of several kinases in various cellular contexts (Ha et al., 2009).  Therefore, 
we postulate that TRAF6 regulates neurite outgrowth via its interaction with PAK, 
possibly binding to the kinase to suppress its activity.  It will be interesting to 
evaluate the activity of PAK downstream of MAIs, particularly MAG, and analyze 
whether a functional link between PAK and TRAF6 exists in neurite outgrowth 
regulation.   
As an adaptor protein for p75, TRAF6 is recruited to the receptor with neurotrophin 
stimulation (Khursigara et al., 1999).  It is not yet known whether the interaction 
between TRAF6 and p75 is affected by other MAIs.  We show that overexpression of 
NgR, a receptor for Nogo, MAG, and OMgp, disrupts binding of p75 and TRAF6.  It 
is possible that NgR overexpression is similar to MAI binding, which enhances the 
interaction between NgR and p75.  To further assess the role of MAI signaling on 
binding of TRAF6 to p75, future studies will need to be conducted in neuronal cells in 
response to inhibitory ligands.  Release of TRAF6 from p75 may be an important 
step in its regulation of neurite outgrowth.  Release of TRAF6 could free it to 
complex with other proteins in order to regulate outgrowth.  I propose that upon its 
displacement, TRAF6 interacts with PAK to modulate its activity and inhibit 
outgrowth. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Damage to the CNS such as occurs in spinal cord injuries, results in permanent 
damage and disability due to the limited capacity of CNS axons to regenerate.  CNS 
myelin has emerged as one of the main barriers to axon regeneration.  Following 
injury, myelin is a major source of growth-inhibitory ligands that interact with the 
axon surface to regulate axonal capacity for growth.  In the work described in the 
previous chapters, we investigated the molecular mechanisms involved in the 
inhibition of neurite outgrowth by one of these myelin inhibitors, Myelin-associated 
glycoprotein (MAG) (Figure 5.1).     
Diverse axonal tracts respond uniquely to spinal cord injury and it is speculated that 
different strategies may be required to achieve regeneration of various neuronal 
populations.  Surprisingly, very few studies to date have investigated the response of 
cortical neurons to MAIs and the mechanisms of cortical neuron outgrowth inhibition 
by these proteins.  We found that cortical neurons were particularly vulnerable to 
neurite outgrowth inhibition by MAG. Interfering with the function of known MAG 
receptors did not reverse outgrowth of cortical neurons on membrane bound MAG, 
indicating that other receptors exist to mediate the substantial outgrowth inhibition 
observed.  These results confirm and extend recent findings showing that the 
previously identified MAG receptors were not required for the inhibitory effects of 
MAG in some neuronal populations. Thus far the receptors for the classic MAIs, 
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Figure 5.1.  Schematic illustrating novel mechanisms of neurite outgrowth 
inhibition by MAG.  The work described in the previous chapters is summarized 
here.  We demonstrated that membrane bound MAG signals through Rho and PTEN 
to inhibit cortical neurite outgrowth.  We found that membrane bound MAG does not 
require its known receptors in cortical neurite outgrowth inhibition and likely utilizes an 
unidentified receptor to mediate its inhibitory effect.  TRAF6 is required for neurite 
outgrowth inhibition by soluble, but not membrane bound MAG.  We identified an 
interaction between TRAF6 and PAK and hypothesize that this association may play a 
functional role in neurite outgrowth inhibition by soluble MAG.    
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such as NgR and PirB, have been identified in screens for Nogo-66 binding partners 
(Fournier et al., 2001; Atwal et al., 2008).  Future studies should focus on identifying 
receptors for MAG, particularly the membrane bound form.  One approach would be 
an expression screen with a CNS cDNA library for MAG binding partners.  Another 
approach that would allow us to identify receptors for MAG with a function in neurite 
outgrowth inhibition would be a siRNA screen in cortical neurons.  siRNA transfected 
neurons would be plated on MAG-CHO or control CHO cells and examined for 
reversal of inhibition by MAG.  Our finding that p75 was not required for neurite 
outgrowth inhibition by MAG in cortical neurons or CGNs, but Rho/ROCK signaling 
was, suggests that other receptors exist to activate Rho downstream of MAG.  To 
identify Rho activating receptors involved in MAG signaling I suggest a future study 
utilizing a siRNA library targeting known receptors combined with in situ visualization 
of Rho activation in neurons to detect lack of GTPase activation by MAG.  Identifying 
additional receptors, unique to MAG, will benefit not only the regeneration field, but 
may shed some light on other MAG functions, since the axonal receptors important 
for maintenance of myelin stability, structuring of Nodes of Ranvier, and regulation of 
neurofilaments have yet to be identified.  
It is likely that various inhibitors and receptors contribute to inhibition of corticospinal 
tract regeneration and our work highlights the importance of future efforts to 
characterize mechanisms of cortical axon outgrowth regulation.  A recent study 
demonstrated that knockout of the three major MAIs, MAG, Nogo, and OMgp, did 
not result in significant regrowth of the corticospinal tract following injury (Lee et al., 
2010), suggesting the presence of other inhibitory cues. To investigate additional 
inhibitory signals and neuronal receptors involved in preventing corticospinal tract 
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regrowth, gene expression profiling of the injury site may prove useful.  Comparison 
of genes altered in corticospinal tract injury to uninjured spinal cord and injured 
peripheral nerve would allow us to identify CNS specific genes regulated by injury.  
Such a study will undoubtedly yield a vast number of genes with altered expression, 
not all involved in outgrowth inhibition.  In order to identify potential inhibitors of 
outgrowth, I would focus on genes with known cytoskeletal functions.  Another 
approach would be to limit the search to proteins known to regulate axonal 
outgrowth during development.  During development, positive and negative 
extracellular cues ensure that axons reach their appropriate targets.  Semaphorins 
and ephrins, known regulators of axonal pathfinding during development, were 
identified as inhibitors present on myelin capable of inhibiting outgrowth (Moreau-
Fauvarque et al., 2003; Benson et al., 2005).   Developmental cues may resurface 
following injury to prevent outgrowth.  I would also focus on less acute phases 
following injury when the injury site becomes more stable, while neurons are still 
alive but after the peak of inflammation and glial cell death. 
One of the main signaling pathways that mediates inhibition of neurite outgrowth by 
MAG, Nogo and OMgp is Rho GTPase and its effector ROCK.  Our results show that 
Rho and ROCK play an important role in cortical neurite outgrowth inhibition by 
MAG.  However, inhibition of Rho or ROCK did not fully reverse neurite outgrowth 
inhibition by MAG.  This finding is important because it is the first observation that 
inhibition of Rho or ROCK does not fully reverse inhibition by MAG and prompted us 
to search for other signals in cortical neurons employed by MAG to mediate its effect 
on neurite outgrowth.  Rho GTPAse has been one of the key targets in vivo to 
promote regeneration following injury (Lehmann et al., 1999; Dergham et al., 2002; 
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Fournier et al., 2003).  It is important to identify and understand other potential 
pathways that can be targeted to promote axonal outgrowth in vivo in order to obtain 
optimal regeneration and functional recovery.  
The work presented here identifies PTEN as a novel mediator of neurite outgrowth 
inhibition by membrane bound MAG.  Our work also suggests that MAG (or other 
extracellular signals) may contribute to activating PTEN following injury.  It will be 
interesting to assess whether PTEN or Akt activities are affected at injury sites.  
Future studies evaluating regeneration of the corticospinal tract following injury in 
PTEN conditional knockout mice will reveal whether PTEN also negatively regulates 
cortical axon outgrowth in vivo.  In fact, one study was just published showing that 
adult cortical axons with PTEN deleted regrew to form synapses in the spinal cord 
following injury, supporting a role for PTEN in preventing regeneration of cortical 
neurons (Liu et al., 2010).  The findings presented here also indicate that 
manipulation of Rho and PTEN function may have an additive effect on corticospinal 
tract regrowth in vivo. 
The finding that MAG may contribute to the regulation of PTEN and its role as a 
negative regulator of axon outgrowth raises the question of whether there are other 
extrinsic cues that regulate PTEN signaling after injury. Other MAIs or other 
extracellular signals such as those produced by the glial scar may regulate PTEN to 
exert their growth inhibitory effect.  In fact, the levels of regeneration attained in vivo 
with PTEN conditional knockout mice, indicates that PTEN may be a major 
convergence point for multiple inhibitory signals since the axonal outgrowth 
observed was so significantly above that seen with deletions of various inhibitors or 
their receptors (Yiu and He, 2006; Park et al., 2008; Liu et al., 2010).  Chadborn et 
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al. (2006) demonstrated that Sema3A, a known axon guidance molecule during 
development, engaged PTEN to induce growth cone collapse.  Identification of 
extrinsic cues that like MAG and Sema3A regulate neurite outgrowth through PTEN 
could also enhance our understanding of PTEN function during neuronal 
development. 
Although our work indicates that PTEN is regulated by MAG, we have not directly 
shown this. In fact, other PIP3 phosphatases, such as SHIP1 and SHIP2, can also 
modulate levels of PIP3 in the cell (Leslie 2002).  Future studies investigating effects 
of MAG on PTEN activity or localization are required.  PTEN phosphatase assays 
following immunoprecipitation of PTEN from cortical neurons exposed to MAG can 
be conducted to evaluate the effect of MAG on PTEN activity.  We can investigate 
the requirement for PTEN’s phosphatase function by conducting neurite outgrowth 
assays with cortical neurons over-expressing a PTEN mutant lacking its lipid 
phosphatase function.  One of the ways by which PTEN is activated in the cell is by 
recruitment to the plasma membrane (Leslie et al., 2008).  Sema3A induced 
membrane localization of PTEN in growth cone collapse (Chadborn et al., 2006).  
The localization of PTEN in response to MAG can be analyzed by comparing the 
localization of GFP tagged PTEN in neurons encountering MAG-CHO cells or control 
CHO cells.  In an effort to investigate changes in PIP3 levels at the plasma 
membrane in response to MAG we imaged neurons expressing a GFP tagged 
pleckstrin homology domain of Akt (PH-GFP) on MAG-CHO and control CHO cells 
by confocal microscopy.  However, we did not observe any reproducible differences 
in PH-GFP membrane localization between neurons on control and MAG expressing 
cells.  PTEN regulation is still not well understood, but in addition to membrane 
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recruitment, PTEN is also regulated by reactive oxygen species, phosphorylation, 
and ubiquitination (See Chapter 3 Discussion) (Drinjakovic et al., 2010).  Future 
studies will need to be carried out to elucidate how PTEN is affected by MAG.  
Our results suggest that MAG can modulate Akt signaling, likely by employing PTEN 
to reduce Akt activity. To confirm that changes in Akt phosphorylation by MAG 
require PTEN, we can evaluate whether Akt phosphorylation is decreased in 
response to MAG in PTEN knockout neurons. Although PTEN’s main function is the 
reduction of PI3K/Akt activity, other functions are emerging for PTEN as both a lipid 
and protein phosphatase (Knobbe et al., 2002; Keniry and Parsons, 2008); hence, 
PTEN may have additional targets that contribute to inhibition of neurite outgrowth 
by MAG.  
It will also be interesting to characterize Akt downstream pathways affected by MAG.  
Several pathways have been implicated in Akt mediated effects on neurite outgrowth 
including other kinases, cytoskeletal proteins, and transcription factors.  GSK3β 
plays a role in modulating neurite outgrowth downstream of PI3K/Akt (Yoshimura et 
al., 2006).  The Akt pathway can also influence the cytoskeleton by direct 
phosphorylation of several cytoskeletal proteins such as tau, Girdin and peripherin or 
by influencing Rac1, a major cytoskeletal regulator (Read and Gorman, 2009).  
Transcription factors downstream of Akt implicated in the effects of Akt on neurite 
outgrowth include CREB and NF-kB (Du and Montminy, 1998; Ozes et al., 1999; 
Jessen et al., 2001; Gutierrez et al., 2005).  Regulation of mTOR signaling may also 
be involved downstream of Akt.  In their characterization of PTEN as a negative 
regulator of axon outgrowth in optic nerve injury, Park et al. (2008) proposed mTOR 
dependent and independent mechanism of regeneration. Furthermore, although the 
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role of Akt in neurite outgrowth has been studied in various neuron populations, little 
is known about the role of Akt in cortical neuron development or regeneration of 
cortical pathways following injury, both important areas for future study.  
In addition to evaluating mechanisms of neurite outgrowth inhibition by membrane 
bound MAG, we were also interested in investigating signaling by soluble MAG.  The 
functional significance of soluble MAG in vivo is unknown.  However, disease related 
changes in soluble MAG levels have been demonstrated.  Increased soluble MAG 
was detected in brains of individuals with multiple sclerosis for instance (Moller et al., 
1987).  It is possible that MAG release is stimulated at the injury site.  Matrix 
metalloproteinases (MMPs) have been shown to promote release of the extracellular 
domain of MAG from MAG expressing CHO cells (Milward et al., 2008).  
Furthermore, several MMPs are upregulated at the injury site (Rosenberg, 1995).  
Future studies on soluble MAG should focus on investigating its relevance in neurite 
outgrowth inhibition following injury.  We have obtained frozen spinal cords from rats 
subjected to spinal cord crush or transection from Mark Tuszynski (UCSD).  We will 
conduct Western blot analysis of these injured spinal cords to detect the presence of 
soluble and membrane bound MAG as well as compare differences between injured 
and uninjured spinal cords.  A comparison of soluble MAG levels in injured CNS 
tissue versus PNS tissue may also provide insight regarding the growth inhibitory 
role of soluble MAG. I postulate that soluble MAG and membrane bound MAG both 
contribute to inhibition of axonal growth following injury.   
Work presented here indicates that soluble and membrane bound MAG utilize 
differential mechanisms to exert their effect on outgrowth inhibition. One possible 
explanation for the differences observed between soluble and membrane bound 
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MAG is that the soluble form mediates a more acute effect at the growth cone, such 
as growth cone collapse, while signaling by membrane bound MAG provides a more 
continuous inhibitory signal preventing forward movement of the growth cone.  
Schwab  (2009) demonstrated that soluble MAG can be internalized by the axon and 
retrogradely transported to the cell body.  Perhaps soluble MAG binding results in 
acute collapse followed by internalization of the ligand, which may further inhibit 
neurite outgrowth or mediate other functions. It is possible that p75 is retrogradely 
trafficked in response to soluble MAIs.  Proteolytic cleavage of p75 and release of its 
intracellular domain has been suggested as an important step in neurite outgrowth 
inhibition by soluble MAG (Domeniconi et al., 2005). There is also evidence for 
retrograde trafficking of the intracellular domain of p75 in response to neurotrophins 
(Lalli and Schiavo, 2002; Deinhardt et al., 2006), with a possible translocation of p75 
to the nucleus (Parkhurst et al., 2010).  I hypothesize that MAG retrograde 
trafficking, possibly with p75, may be involved in regulating genes involved in 
mediating and maintaining neurite outgrowth inhibition.  In addition to activating 
signaling cascades that ultimately regulate the cytoskeleton, it is likely that myelin 
proteins also induce changes in gene expression to exert more long-lasting inhibition 
of outgrowth.  The observation of MAG retrograde trafficking by MAG (Schwab 2009) 
backs future studies investigating changes in neuronal gene expression by MAG.        
We found that the absence of TRAF6 in CGNs resulted in a neuronal phenotype that 
was resistant to neurite outgrowth inhibition by soluble MAG.  It will be interesting to 
evaluate whether TRAF6 is also required for neurite outgrowth inhibition by Nogo or 
OMgp.  A role for TRAF6 downstream of other MAIs would establish TRAF6 as an 
important mediator of myelin signaling.  To elucidate the physiological importance of 
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TRAF6 in axon regeneration an in vivo mouse injury model can be evaluated for the 
ability of traf6 null axons to regenerate.  I expect that if TRAF6 does indeed play a 
role in axon outgrowth inhibition in the CNS, traf6 null animals will display enhanced 
regeneration compared to wild-type.   
I postulate that TRAF6 is activated by MAIs, which can be evaluated by increased 
ubiquitination of the protein, to regulate downstream signaling events leading to 
inhibition of outgrowth.  We identified an interaction between TRAF6 and PAK and 
propose that this interaction plays a role in regulation of neurite outgrowth by MAG.  
Future studies should be conducted to evaluate the effect of MAG on PAK activity as 
well as evaluating the requirement for PAK in MAG outgrowth inhibition.  To 
investigate a role for TRAF6 in PAK regulation downstream of MAIs, any effect of 
MAG on PAK activity should be assessed in traf6 null neurons.  I expect that if 
TRAF6 regulates PAK function or is part of a complex that does, its interaction with 
PAK may be inducible by MAG.  I anticipate that TRAF6 acts to modulate PAK, likely 
by ubiquitinating the kinase to inhibit its activity and thus negatively regulate neurite 
outgrowth.  We may find that TRAF6 does not interact with PAK to regulate its 
activity, but instead binds to PAK and modulates the ability of PAK to regulate its 
downstream targets.  Alternatively, PAK may modulate the ability of TRAF6 to 
activate its downstream targets, such as NFkB, JNK, or Src (Ha et al., 2009). 
Perhaps even more importantly, the interaction between TRAF6 and PAK may have 
significant implications for other cellular processes regulated by these proteins.  
TRAF6 is known to regulate several kinases in a variety of contexts.  TRAF6 may 
function to ubiquitinate PAK and modulate its function in processes such as cell 
motility, survival and cell cycle regulation.  If so, this interaction may be important 
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during development and in various cancers and neuronal disorders in which PAK 
regulation is implicated (Molli et al., 2009).   Investigating a role for PAK in known 
TRAF6 functions could also reveal novel signaling pathways in TNFR family 
signaling. 
Lastly, the findings described in this dissertation may have implications for other 
processes mediated by MAG including emerging novel functions for myelin proteins.  
During development of the nervous system, establishment of appropriate 
connections involves degeneration and pruning of axons (Carter, 2010).  Recent 
findings suggest that this process also occurs in the mature nervous system in order 
to eliminate aberrant sprouting and maintain axons on a narrow path (Park et al., 
2010a).  Myelin is a negative regulator of irregular sprouting through its role in 
triggering degeneration of neuronal processes (Park et al., 2010a).  Moreover, the 
pathways involved in degeneration of axons by myelin were distinct from those 
involved in inhibition of outgrowth.  It will be exciting to investigate whether MAIs, 
including MAG, also function normally to keep axons on a straight path.  A role for 
OMgp in preventing axonal sprouting at Nodes of Ranvier has been shown (Huang 
et al., 2005).  Whether other MAIs function in this capacity will be an interesting area 
for future study.  The end of plasticity in the cortex occurs at a time that corresponds 
with completion of myelination, suggesting that myelin may contribute to limiting 
refinement of neuronal circuitry.  Interestingly, one study found that mice lacking 
NgR exhibited an extended period of plasticity in the visual cortex, suggesting that 
MAIs and their associated signaling pathways may also play a role in this process 
(McGee et al., 2005).  
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Gaining a more complete understanding of the different mechanisms employed by 
myelin-associated inhibitors in specific neuron types could help in developing 
therapeutics that will be effective for specific fiber tracts and brain regions following 
injury.   Our results with cortical neurons suggest that in addition to Rho/ROCK, 
PTEN is another therapeutic target that may enhance regeneration of these neurons.  
Furthermore, the identification of PTEN and TRAF6 as downstream effectors of 
MAG in preventing neurite outgrowth may have important implications for other 
processes mediated by MAG. 
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